C-Bond Systems (CBNT) 10-K 15 Apr 22 2021 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Apr. 14, 2022	Jun. 30, 2021
Document Information Line Items
Entity Registrant Name	C-BOND SYSTEMS, INC.
Trading Symbol	N/A
Document Type	10-K
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		285,174,171
Entity Public Float			$ 6,589,961
Amendment Flag	false
Entity Central Index Key	0001421636
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2021
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
ICFR Auditor Attestation Flag	false
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-53029
Entity Incorporation, State or Country Code	CO
Entity Tax Identification Number	26-1315585
Entity Address, Address Line One	6035 South Loop East
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77033
City Area Code	(832)
Local Phone Number	649-5658
Title of 12(b) Security	N/A
Security Exchange Name	NONE
Entity Interactive Data Current	Yes
Auditor Firm ID	106
Auditor Name	Salberg & Company, P.A.
Auditor Location	Boca Raton, Florida

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash	$ 519,898	$ 323,407
Accounts receivable, net	173,248	79,697
Inventory	82,931	77,200
Prepaid expenses and other current assets	151,746	50,723
Contract assets	82,805
Due from related party	3,750	5,526
Total Current Assets	1,014,378	536,553
OTHER ASSETS:
Property and equipment, net	135,022	18,683
Right of use asset, net	251,172	21,772
Intangible asset, net	330,421
Goodwill	350,491
Security deposit	6,482	7,132
Total Other Assets	1,073,588	47,587
TOTAL ASSETS	2,087,966	584,140
CURRENT LIABILITIES:
Convertible note payable, net	171,875
Note payable, current portion	488,414	521,138
Accounts payable	831,648	794,905
Accrued expenses	436,733	186,765
Accrued compensation	691,602	425,797
Contract liabilities	10,426
Lease liability, current portion	44,927	22,216
Total Current Liabilities	2,675,625	1,950,821
LONG-TERM LIABILITIES:
Note payable, net of current portion	539,440	35,062
Lease liability, net of current portion	206,319
Total Long-term Liabilities	745,759	35,062
Total Liabilities	3,421,384	1,985,883
Commitments and Contingencies (See Note 11)
Series B convertible preferred stock: $0.10 par value, 100,000 shares designated; 722 and 427 shares issued and outstanding at December 31, 2021 and 2020, respectively ($738,611 redemption and liquidation value at December 31, 2021)	738,611	429,446
Series C convertible preferred stock: $0.10 par value, 100,000 shares designated; 18,680 and 13,300 shares issued and outstanding at December 31, 2021 and 2020, respectively ($2,860,518 redemption and liquidation value at December 31, 2021)	1,907,012	1,336,031
SHAREHOLDERS’ DEFICIT:
Preferred stock: $0.10 par value, 2,000,000 shares authorized; 100,000 Series B and 100,000 Series C designated
Common stock: $0.001 par value, 4,998,000,000 shares authorized; 282,216,632 and 228,346,974 issued and outstanding at December 31, 2021 and 2020, respectively	282,217	228,347
Additional paid-in capital	53,064,616	42,573,272
Accumulated deficit	(57,515,129)	(45,968,839)
Total C-Bond Systems, Inc. shareholders’ deficit	(4,168,296)	(3,167,220)
Noncontrolling Interest	189,255
Total Shareholders’ Deficit	(3,979,041)	(3,167,220)
Total Liabilities and Shareholders’ Deficit	$ 2,087,966	$ 584,140

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Preferred stock, shares authorized	2,000,000	2,000,000
Common stock , par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock , shares authorized	4,998,000,000	4,998,000,000
Common stock , shares issued	282,216,632	228,346,974
Common stock , shares outstanding	282,216,632	228,346,974
Series B
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Preferred stock, shares designated	100,000	100,000
Preferred stock, shares issued	722	427
Preferred stock, shares outstanding	722	427
Share redemption and liquidation value (in Dollars)	$ 738,611
Preferred stock, shares designated	100,000	100,000
Series C
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Preferred stock, shares designated	100,000	100,000
Preferred stock, shares issued	18,680	13,300
Preferred stock, shares outstanding	18,680	13,300
Share redemption and liquidation value (in Dollars)	$ 2,860,518
Preferred stock, shares designated	100,000	100,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
SALES:
Third parties	$ 1,475,628	$ 555,863
Related party	1,200
Total Sales	1,476,828	555,863
COST OF SALES (excluding depreciation expense)	657,298	242,506
GROSS PROFIT	819,530	313,357
OPERATING EXPENSES:
Compensation and related benefits (including stock-based compensation of $4,085,868 and $2,108,472 for the years ended December 31, 2021, and 2020, respectively)	6,165,006	3,741,051
Research and development	(3,250)	16,627
Professional fees	1,031,540	546,979
General and administrative expenses	636,353	485,733
Total Operating Expenses	7,829,649	4,790,390
LOSS FROM OPERATIONS	(7,010,119)	(4,477,033)
OTHER INCOME (EXPENSES):
Gain on debt extinguishment, net	96,442	877,823
Other income	67,778	6,574
Derivative expense		(90,623)
Interest expense	(282,959)	(751,184)
Total Other (Expenses) Income	(118,739)	42,590
NET LOSS	(7,128,858)	(4,434,443)
Net income of subsidiary attributable to noncontrolling interest	(15,525)
Preferred stock dividend and deemed dividend	(4,401,907)	(1,534,381)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (11,546,290)	$ (5,968,824)
NET LOSS PER COMMON SHARE:
Basic and diluted (in Dollars per share)	$ (0.05)	$ (0.03)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic and diluted (in Shares)	254,299,139	172,978,187

Consolidated Statements of Op_2

Consolidated Statements of Operations (Parentheticals) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Stock-based compensation	$ 4,085,868	$ 2,108,472

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders’ Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest	Total
Balance at Dec. 31, 2019	$ 116,750	$ 37,266,328	$ (40,000,015)		$ (2,616,937)
Balance (in Shares) at Dec. 31, 2019	116,749,633
Shares issued for conversion of accounts payable	$ 151	5,907			6,058
Shares issued for conversion of accounts payable (in Shares)	151,456
Shares issued for conversion of accrued compensation	$ 751	28,102			28,853
Shares issued for conversion of accrued compensation (in Shares)	751,070
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation		1,048,143			1,048,143
Common shares issued for cash	$ 37,390	783,610			821,000
Common shares issued for cash (in Shares)	37,390,314
Common shares issued for conversion of debt, accrued interest and fees	$ 37,172	153,857			191,029
Common shares issued for conversion of debt, accrued interest and fees (in Shares)	37,171,800
Common shares issued for services	$ 20,000	129,475			149,475
Common shares issued for services (in Shares)	20,000,000
Extinguishment loss related to conversion of debt		297,919			297,919
Common shares issued for conversion of Series A preferred shares and dividends	$ 16,133	199,291			215,424
Common shares issued for conversion of Series A preferred shares and dividends (in Shares)	16,132,701
Issuance of warrants in connection with convertible debt		14,498			14,498
Reclassification of put premium to equity upon conversion of Series A preferred		49,543			49,543
Accretion of stock-based compensation		446,064			446,064
Accretion of stock-based professional fees		15,000			15,000
Accretion of stock option expense		609,662			609,662
Preferred stock dividends and deemed dividend		1,525,873	(1,534,381)		(8,508)
Net loss			(4,434,443)		(4,434,443)
Balance at Dec. 31, 2020	$ 228,347	42,573,272	(45,968,839)		(3,167,220)
Balance (in Shares) at Dec. 31, 2020	228,346,974
Common shares issued for accounts payable	$ 3,801	114,037			117,838
Common shares issued for accounts payable (in Shares)	3,801,224
Common shares issued for acquisition	$ 28,021	666,900			694,921
Common shares issued for acquisition (in Shares)	28,021,016
Common shares issued for professional fees	$ 13,250	540,950			554,200
Common shares issued for professional fees (in Shares)	13,250,000
Common shares issued for compensation	$ 4,677	19,736			24,413
Common shares issued for compensation (in Shares)	4,676,500
Common shares issued for accrued compensation	$ 945	54,796			55,741
Common shares issued for accrued compensation (in Shares)	944,767
Common shares issued for cashless warrant exercise	$ 1,008	(1,008)
Common shares issued for cashless warrant exercise (in Shares)	1,008,000
Common shares issued for conversion of Series C preferred stock	$ 1,500	10,500			12,000
Common shares issued for conversion of Series C preferred stock (in Shares)	1,500,000
Common stock issued in connection with convertible debt	$ 668	13,396			14,064
Common stock issued in connection with convertible debt (in Shares)	668,151
Preferred stock dividends and deemed dividend		4,354,761	(4,401,907)		(47,146)
Initial noncontrolling in acquired business				173,730	173,730
Beneficial conversion feature connection with convertible debt		318,794			318,794
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation		3,778,810			3,778,810
Issuance of warrants in connection with convertible debt		347,142			347,142
Accretion of stock-based compensation		267,530			267,530
Accretion of stock-based professional fees		5,000			5,000
Net loss			(7,144,383)	15,525	(7,128,858)
Balance at Dec. 31, 2021	$ 282,217	$ 53,064,616	$ (57,515,129)	$ 189,255	$ (3,979,041)
Balance (in Shares) at Dec. 31, 2021	282,216,632

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (7,128,858)	$ (4,434,443)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	45,967	14,093
Amortization of debt discount to interest expense	171,875	424,001
Accretion of preferred shares stated value to interest expense		52,400
Stock-based compensation	4,085,868	2,108,472
Stock-based professional fees	478,129	132,892
Bad debt expense	39,355	99,911
Allowance for obsolete inventory	45,000
Interest expense related to put premium on convertible debt		47,405
Gain on sale of property and equipment	(13,000)
Derivative expense		90,623
Non-cash gain on debt extinguishment	(96,442)	(877,823)
Non-cash fees upon conversion		2,500
Lease costs	(370)	400
Change in operating assets and liabilities:
Accounts receivable	(73,180)	(27,619)
Inventory	17,288	(62,380)
Prepaid expenses and other assets	(13,211)	(563)
Contract assets	(50,106)
Due from related party	1,776	(5,526)
Accounts payable	88,853	139,300
Accrued expenses	92,148	96,022
Customer deposit	(110,000)
Accrued compensation	601,431	417,308
Contract liabilities	10,426
NET CASH USED IN OPERATING ACTIVITIES	(1,807,051)	(1,783,027)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash proceeds from sale of property and equipment	13,000
Cash received from acquisition	288,901
NET CASH PROVIDED BY INVESTING ACTIVITIES	301,901
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock		821,000
Proceeds from sale of series A preferred stock		120,000
Redemption of Series A preferred stock		(104,762)
Proceeds from sale of series C preferred stock	550,000	1,330,000
Proceeds from exercise of stock options
Proceeds from note payable	500,000	156,200
Repayment of notes payable	(28,359)
Proceeds from convertible notes payable	680,000	100,000
Repayment of convertible note payable		(393,215)
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,701,641	2,029,223
NET INCREASE IN CASH	196,491	246,196
CASH, beginning of year	323,407	77,211
CASH, end of year	519,898	323,407
Cash paid for:
Interest	53,283	130,399
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Common stock issued as prepaid for services	98,800	133,000
Common stock issued for accrued compensation	40,626	24,250
Series B preferred stock issued for accrued compensation	295,000	318,969
Common stock issued for accounts payable	117,838	6,058
Common stock issued for debt and accrued interest		188,529
Reclassification of put premium to equity		8,508
Preferred stock dividend accrued	47,146	1,525,873
Deemed dividend related to beneficial conversion feature of Series C preferred shares	4,354,761	49,543
Increase in debt discount and derivative liability		85,502
Increase in debt discount and paid-in capital for warrants, shares and beneficial conversion	680,000	14,498
Conversion of series C preferred stock to common stock	12,000
ACQUISITION:
Cash	288,901
Accounts receivable, net	59,726
Inventory	68,019
Prepaid expenses	6,091
Contract assets	32,699
Property and equipment	140,211
Right of use assets	253,433
Total assets acquired	849,080
Less: liabilities assumed:
Accounts payable	65,728
Accrued expenses	159,262
Notes payable	95,013
Customer deposit	110,000
Lease liabilities	253,433
Noncontrolling interest	173,730
Total liabilities assumed	857,166
Net liabilities assumed	8,086
Fair value of shares for acquisition	694,921
Increase in intangible assets - non-cash	$ 703,007

Nature of Organization

Nature of Organization	12 Months Ended
	Dec. 31, 2021
Nature of Organization [Abstract]
NATURE OF ORGANIZATION	NOTE 1 - NATURE OF ORGANIZATION Nature of Organization C-Bond Systems, Inc. and its subsidiaries (the “Company”) is a materials development company and sole owner, developer, and manufacturer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s present primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. Additionally, the Company has expanded its product line to include disinfection products. The Company operates in two divisions: C-Bond Transportation Solutions, which sells a windshield strengthening water repellent solution as well as a disinfection product, and Patriot Glass Solutions, which sells multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system. On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Shareholder”), and (iii) Michael Wanke as the Representative of the Mobile Shareholder. Pursuant to the Exchange Agreement, C-Bond agreed to acquire 80% of Mobile’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Mobile Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Shares. The Mobile Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing as defined in the Exchange Agreement. Two years after closing, the Company has the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement (the “Additional Closing”) (see Note 3). Mobile provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Mobile also carry products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Mobile’s owner-operator, Michael Wanke, joined the Company as President of its Safety Patriot Glass Solutions Group.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The Company’s consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC and its 80% owned subsidiary, Mobile Tint LLC since acquiring 80% of Mobile Tint LLC on July 22, 2021. All significant intercompany accounts and transactions have been eliminated in consolidation. Going Concern These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had a net loss of $7,128,858 and $4,434,443 for the years ended December 31, 2021 and 2020, respectively. The net cash used in operations was $1,807,051 and $1,783,027 for the years ended December 31, 2021 and 2020, respectively. Additionally, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $57,515,129, $3,979,041 and $1,661,247, respectively, on December 31, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. These consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the years ended December 31, 2021 and 2020 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, purchase price allocation of acquired businesses, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the fair value of derivative liabilities, the value of beneficial conversion features, and the fair value of non-cash equity transactions. Fair Value of Financial Instruments and Fair Value Measurements The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Disclosures about the fair value of financial instruments are based on pertinent information available to the Company on December 31, 2021 and 2020. Accordingly, the estimates presented in these consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. FASB Accounting Standards Codification (“ASC”) 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2—Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3—Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, notes payable – related party, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liability approximate their fair market value based on the short-term maturity of these instruments. Assets and liabilities measured at fair value on a recurring basis on December 31, 2021 and 2020 is as follows: On December 31, 2021 On December 31, 2020 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ - $ - $ - $ - $ - $ - A roll forward of the level 3 valuation financial instruments is as follows: For the Year Ended 2021 2020 Balance at beginning of period $ - $ 890,410 Initial valuation of derivative liabilities included in debt discount - 85,502 Initial valuation of derivative liabilities included in derivative expense - 160,416 Gain on extinguishment of debt related to repayment/conversion of debt - (1,066,535 ) Change in fair value included in derivative expense - (69,793 ) Balance at end of period $ - $ - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments. Cash And Cash Equivalents For purposes of the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. The Company has no cash equivalents as of December 31, 2021 and 2020. Accounts Receivable The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future write-offs, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible. The expense associated with the allowance for doubtful accounts is recognized as general and administrative expense. Inventory Inventory, consisting of raw materials and finished goods, are stated at the lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of sales. Property And Equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from one to five years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable. Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over a useful life of 5 years. Impairment of Long-Lived Assets In accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. Derivative Financial Instruments The Company had certain financial instruments that were embedded derivatives. The Company evaluated all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4, Derivatives and Hedging Contracts in Entity’s Own Equity In July 2017, FASB issued Accounting Standards Update (“ASU”) No. 2017-11, Earnings Per Share Distinguishing Liabilities from Equity Derivatives and Hedging Accounting for Certain Financial Instruments with Down Round Features Revenue Recognition The Company follows ASC Topic 606, Revenue from Contracts with Customers The Company sells its products which include standard warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation. Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized. Cost of Sales Cost of sales includes inventory costs, packaging costs and warranty expenses. Cost of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements, are accounted for as changes in estimates in the current period. Shipping and Handling Costs Shipping and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $15,431 and $49,515 for the year ended December 31, 2021 and 2020, respectively. Shipping and handling costs charged to customers are included in sales. Research and Development Research and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated costs incurred. For the year ended December 31, 2021 and 2020, research and development costs (recovery) incurred in the development of the Company’s products were $(3,250) and $16,627, respectively, and are included in operating expenses on the accompanying consolidated statements of operations. In April 2021, the Company received a refund of research and development costs of $3,250. Warranty Liability The Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted $26,733 and $26,833 on December 31, 2021 and 2020, respectively. For the years ended December 31, 2021 and 2020, warranty costs amounted to $100 for both periods which has been deducted from warranty liability. For the years ended December 31, 2021 and 2020, a roll forward of warranty liability is as follows: For the Year Ended 2021 2020 Balance at beginning of period $ 26,833 $ 26,933 Warranty costs incurred (100 ) (100 ) Balance at end of period $ 26,733 $ 26,833 Advertising Costs The Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the year ended December 31, 2021 and 2020, advertising costs charged to operations were $65,626 and $46,276, respectively and are included in general and administrative expenses on the accompanying consolidated statements of operations. These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales. Federal and State Income Taxes The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes Stock-Based Compensation Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation Improvements to Employee Share-Based Payment Loss Per Common Share ASC 260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in the future. All potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net losses and consisted of the following: December 31, 2021 2020 Stock options 8,445,698 8,445,698 Warrants 17,500,000 2,050,000 Series B preferred stock 114,598,413 68,166,032 Series C preferred stock 296,507,937 211,111,111 Convertible debt 33,000,000 - Non-vested, forfeitable common shares 14,270,120 23,826,926 484,322,168 313,599,767 Segment Reporting During the year ended December 31, 2020, the Company operated in one reportable business segment, which consisted of the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system. During the year ended December 31, 2021, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions. The Company’s reportable segments were strategic business units that offered different products. They were managed separately based on the fundamental differences in their operations and locations. Leases In February 2016, the FASB issued ASU 2016-02, “ Leases (Topic 842)” Operating lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the consolidated statements of operations. Noncontrolling Interest The Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total shareholders’ equity on the consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the consolidated statements of operations. Risk and Uncertainties In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended containment and mitigation measures worldwide. The Company is monitoring this closely. The Company has been materially affected by the COVID-19 outbreak to date and the ultimate duration and severity of the outbreak and its impact on the economic environment and our business is uncertain. The Company has seen a material decrease in sales from its international customers as a result of the unprecedented public health crisis from the COVID-19 pandemic and a decrease in domestic sales due to a decrease in business spending on discretionary items. As a result, the Company’s international customers have delayed the ordering of products and have delayed payment of balances due to the Company. As of December 31, 2021 and 2020, the Company recognized an allowance for losses on accounts receivable in an amount of $31,556 and $202,480, respectively. As of December 31, 2020, the allowance for losses on accounts receivable was primarily based on the Company’s assessment of specific identifiable overdue customer accounts located in India and the Philippines. The lack of collection of these accounts receivable balances, which the Company believes was attributable to COVID-19, had a material impact on the cash flows of the Company. The Company cannot estimate the duration of the pandemic and the future impact on its business. A severe or prolonged economic downturn could result in a variety of risks to the Company’s business, including weakened demand for its products and a decreased ability to raise additional capital when needed on acceptable terms, if at all. Currently, the Company is unable to estimate the impact of this event on its operations. Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12 – Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments in ASU 2020-12 eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The amendments in ASU 2019-12 will become effective for us as of the beginning of our 2022 fiscal year. Early adoption is permitted, including adoption in any interim period. We are currently evaluating the impact that this guidance will have upon our financial position and results of operations, if any. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Acquisition of Mobile Tint LLC

Acquisition of Mobile Tint LLC	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
ACQUISITION OF MOBILE TINT LLC	NOTE 3 - ACQUISITION OF MOBILE TINT LLC On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Member”), and (iii) Michael Wanke as the Representative of the Mobile Member. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Mobile’s member units, representing 80% of Mobile’s issued and outstanding membership units (the “Mobile Member Units”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Member Units. The Mobile Member Units were exchanged for restricted shares of the Company’s common stock, in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing as defined in the Exchange Agreement. In connection with the Exchange Agreement, the Company issued 28,021,016 shares of its common stock. These shares were valued at $694,921, or $0.0248 per common share, based on the quoted closing price of the Company’s common stock on July 22, 2021, the measurement date. Two years after closing, the Company has the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement (the “Additional Closing”). The Company also entered into an Amendment to the Exchange Agreement, dated July 21, 2021, which, among other things, stipulates that for U.S. federal income tax purposes the Exchange and the Additional Closing (if exercised) are intended to qualify as a “reorganization” within the meaning of Section 368(a) of the Code and the Treasury Regulations, and the definition of “Total EBIT Value” shall mean Mobile’s net income, before income tax expense and interest expense have been deducted, for the period beginning on July 1, 2021 and ending on June 30, 2023, plus fifty percent (50%) of the Mobile Member’s Base Salary, as defined in the Executive Employment Agreement dated July 21, 2021, between the Mobile Member and the Company (the “Employment Agreement”), as described below. The exchange Agreement transaction documents include the Operating Agreement of Mobile (the “Operating Agreement”) which, among other things, appoints Mr. Wanke, Scott R. Silverman, and Allison Tomek as the Managers of Mobile, and governs the operations of Mobile as outlined therein. Under the terms of the Operating Agreement, the Managers shall not have the authority to perform or approve the following actions, among other things, unless such action is also approved by a unanimous vote: to terminate the existing lease between Company and MDW Management, LLC, an entity owned by Michael Wanke and his spouse; to borrow money for the Company from banks, other lending institutions, the Manager, Members, or affiliates of the Manager or Members; to establish lines of credit in the name of the Company with financial institutions such as banks or other lending institutions; to determine and declare distributions to Members of Mobile. In connection with the Exchange Agreement, the Company entered into a Piggy-Back Registration Rights Agreement dated July 20, 2021 (the “Registration Rights Agreement”) with Mobile, the Mobile Member, and Mr. Wanke, pursuant to which if at any time on or after the date of the closing, the Company proposes to file any Registration Statement (a “Registration Statement”) with respect to any offering of equity securities by the Company for its own account or for shareholders of the Company, other than a Form S-8 Registration Statement, a dividend reinvestment plan, or in connection with a merger or acquisition, then the Company shall (x) give written notice of such proposed filing to the holders of registrable securities no less than ten (10) days before the anticipated filing date of the Registration Statement, and (y) offer to the holders of registrable securities the opportunity to register the sale of either (i) an amount of registrable securities equal to the total number of shares of the Company’s common stock being registered in such Registration Statement that are being offered solely for the Company’s account excluding the registrable securities; or (ii) an amount of registrable securities equal to the total number of shares of the Company’s common stock being registered for resale by shareholders of the Company excluding the registrable securities. In connection with the Exchange Agreement, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Michael Wanke and his wife and tenant Mobile Tint, LLC d/b/a A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Mobile; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Mobile; or (iii) two (2) years from and after the effective date of the guaranty. In connection with the Exchange Agreement, the assets acquired and liabilities assumed were recorded at their estimated fair values on the acquisition date, subject to adjustment during the measurement period with subsequent changes recognized in earnings or loss. These estimates were inherently uncertain and are subject to refinement. Management develops estimates based on assumptions as a part of the purchase price allocation process to value the assets acquired and liabilities assumed as of the business acquisition date. As a result, during the purchase price measurement period, which may be up to one year from the business acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed based on completion of valuations, with the corresponding offset to goodwill. After the purchase price measurement period, the Company will record any adjustments to assets acquired or liabilities assumed in operating expenses in the period in which the adjustments may have been determined. Based upon the purchase price allocation, the following table summarizes the estimated fair value of the assets acquired and liabilities assumed at the date of the respective acquisition: Total Assets acquired: Cash $ 288,901 Accounts receivable, net 59,726 Inventory 68,019 Prepaid expenses and other 6,091 Contract assets 32,699 Property and equipment 140,211 Right of use asset 253,433 Intangible assets 352,516 Goodwill 350,491 Total assets acquired at fair value 1,552,087 Less: total liabilities assumed: Notes payable 95,013 Accounts payable 65,728 Accrued expenses 159,262 Customer deposit 110,000 Lease liability 253,433 Noncontrolling interest 173,730 Total liabilities assumed 857,166 Net assets acquired $ 694,921 Purchase consideration paid: Fair value of common shares issued $ 694,921 Total purchase consideration paid $ 694,921 The following unaudited pro forma consolidated results of operations have been prepared as if the acquisition of Mobile Tint LLC had occurred as of the beginning of the following periods: For the Year Ended For the Year Ended Net Revenues $ 2,168,863 $ 2,635,627 Net Loss $ (7,128,027 ) $ (4,159,008 ) Net Loss per Share $ (0.03 ) $ (0.02 ) Pro forma data does not purport to be indicative of the results that would have been obtained had these events actually occurred at the beginning of the periods presented and is not intended to be a projection of future results.

Accounts Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2021
Accounts Receivable [Abstract]
ACCOUNTS RECEIVABLE	NOTE 4 – ACCOUNTS RECEIVABLE On December 31, 2021 and 2020, accounts receivable consisted of the following: December 31, December 31, (As Restated) Accounts receivable $ 204,804 $ 179,608 Less: allowance for doubtful accounts (31,556 ) (99,911 ) Accounts receivable, net $ 173,248 $ 79,697 (a) For the years ended December 31, 2021 and 2020, bad debt expense amounted to $39,355 and $99,911, respectively. (a) See Note 18 – Restatement for details.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
INVENTORY	NOTE 5 – INVENTORY On December 31, 2021 and 2020, inventory consisted of the following: December 31, December 31, Raw materials $ 7,141 $ 24,477 Finished goods 120,790 52,723 Inventory 127,931 77,200 Less: allowance for obsolete or slow moving inventory (45,000 ) - Inventory, net $ 82,931 $ 77,200 For the years ended December 31, 2021 and 2020, a loss from allowance for slow moving inventory amounted to $45,000 and $0, respectively, and is included in cost of sales on the accompanying consolidated statements of operations.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 6 – PROPERTY AND EQUIPMENT On December 31, 2021 and 2020, property and equipment consisted of the following: Useful Life December 31, December 31, Machinery and equipment 5 - 7 years $ 124,133 $ 50,722 Furniture and office equipment 3 - 7 years 32,306 30,245 Vehicles 1 - 5 years 63,009 55,941 Leasehold improvements 3 - 5 years 45,296 16,701 264,744 153,609 Less: accumulated depreciation (129,722 ) (134,926 ) Property and equipment, net $ 135,022 $ 18,683 During the year ended December 31, 2021, the Company sold a vehicle for proceeds of $13,000 and record a gain on sale of property and equipment of $13,000 which is included in general and administrative expenses on the accompanying consolidated statement of operations. For the years ended December 31, 2021 and 2020, depreciation and amortization expense is included in general and administrative expenses and amounted to $23,872 and $14,093, respectively.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2021
Intangible Assets and Goodwill [Abstract]
INTANGIBLE ASSETS AND GOODWILL	NOTE 7 - INTANGIBLE ASSETS AND GOODWILL On December 31, 2021 and 2020, intangible assets, which were acquired from Mobile Tint in 2021 (See Note 3), consisted of the following: Useful life December 31, December 31, Customer relations 5 years $ 212,516 $ - Non-compete 5 years 40,000 - Trade name - 100,000 - 352,516 - Less: accumulated amortization (22,095 ) - Intangible assets, net $ 330,421 $ - Useful life December 31, December 31, Goodwill - $ 350,491 $ - For the year ended December 31, 2021 and 2020, amortization of intangible assets amounted to $22,095 and $0, respectively. On December 31, 2021, accumulated amortization amounted to $18,595 and $3,500 for the customer relations and non-compete, respectively. Amortization of intangible assets with identifiable useful lives that is attributable to future periods is as follows: Year ending December 31: Amount 2022 $ 50,503 2023 50,503 2024 50,503 2025 50,503 2026 28,409 Total $ 230,421

Convertible Note Payable

Convertible Note Payable	12 Months Ended
	Dec. 31, 2021
Convertible Note Payable [Abstract]
CONVERTIBLE NOTE PAYABLE	NOTE 8 – CONVERTIBLE NOTE PAYABLE 2020 On September 6, 2019 and on December 9, 2019, the Company closed on Securities Purchase Agreements (the “September and December 2019 SPAs”) with an accredited investor. Pursuant to the terms of the September 6, 2019 and December 9, 2019 SPAs, the Company issued and sold to this investor convertible promissory notes in the aggregate principal amount of $430,000 and warrants to purchase up to 1,050,000 shares of the Company’s common stock. The Company received net proceeds of $382,250, net of original issue discount of $45,000 and origination fees of $2,750. These Notes bore interest at 12% per annum. The September 6, 2019 Note was due and payable on June 6, 2020 and the December 9, 2019 Note was due and payable on September 9, 2020. The September 6, 2019 Note and the December 9, 2019 Note were repaid in full on September 11, 2020. On March 30, 2020, the Company closed on a Securities Purchase Agreement (the “March 2020 SPA”) with an accredited investor. Pursuant to the terms of the March 2020 SPA, the Company issued and sold to this investor a convertible promissory note in the aggregate principal amount of $57,750 and a warrant to purchase up to 144,375 shares of the Company’s common stock. The Company received net proceeds of $50,000, net of original issue discount of $5,000 and origination fees of $2,750. The Note bore interest at 12% per annum and was due and payable on December 30, 2020. The March 30, 2020 Note was repaid in full on August 24, 2020 and the 144,375 warrants were cancelled. On April 23, 2020, the Company closed on a Securities Purchase Agreement (the “April 2020 SPA”) with an accredited investor. Pursuant to the terms of the April 2020 SPA, the Company issued and sold to this investor a convertible promissory note in the aggregate principal amount of $57,750 and a warrant to purchase up to 144,375 shares of the Company’s common stock. The Company received net proceeds of $50,000, net of original issue discount of $5,000 and origination fees of $2,750. The Note bore interest at 12% per annum and was due and payable on January 23, 2021. The April 23, 2020 Note was repaid in full on August 24, 2020 and the 144,375 warrants were cancelled. In accordance with the March 2020 SPA and the April 2020 SPA and the related convertible promissory Notes, subject to the adjustments as defined in the respective SPA and Note, the conversion price (the “Conversion Price”) equaled the lesser of: (i) the lowest Trading Price (as defined below) during the previous twenty-five Trading Day period ending on the latest complete Trading Day prior to the date of this Note, and (ii) the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company). The “Variable Conversion Price” meant 60% multiplied by the Market Price (as defined herein) (representing a discount rate of 40%). “Market Price” meant the lowest Trading Price (as defined below) for the Company’s common stock during the twenty-five Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” meant, for any security as of any date, the lesser of: (i) the lowest trade price on the applicable trading market as reported by a reliable reporting service (“Reporting Service”) designated by the Holder or (ii) the closing bid price on the applicable trading market as reported by a Reporting Service designated by the Holder. The Company had the option to prepay the Note at any time prior to its six-month anniversary, subject to pre-payment charges as detailed in the Note, which it did on August 24, 2020. The March 2020 SPA, the April 2020 SPA and the related Notes contained customary representations, warranties and covenants, including certain restrictions on the Company’s ability to sell, lease or otherwise dispose of any significant portion of its assets. The Investor also had the right of first refusal with respect to any future equity offerings (or debt with an equity component) conducted by the Company until the 12-month anniversary of the Closing. The March 2020 SPA, the April 2020 SPA and the related Notes also provided for certain events of default, including, among other things, payment defaults, breaches of representations and warranties, bankruptcy or insolvency proceedings, delinquency in periodic report filings with the Securities and Exchange Commission, and cross default with other agreements. Upon the occurrence of an event of default, this investor could declare the outstanding obligations due and payable at significant applicable default rates and take such other actions as set forth in the Notes. The Warrants are exercisable at any time on or after the date of the issuance and entitles this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrants, the holder is entitled to exercise Warrants to purchase up to an aggregate of 1,050,000 shares of the Company’s common stock at a fixed exercise price of $0.01. On January 7, 2021, the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of the 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant. These Notes and related Warrants included a down-round provision under which the Notes conversion price and warrant exercise price could have been affected by future equity offerings undertaken by the Company. In connection with the issuance of the September and December 2019 Notes, the March 2020 Note and the April 2020 Note, the Company determined that the terms of the Note contain terms that are not fixed monetary amounts at inception. Accordingly, under the provisions of ASC 815-40 - Derivatives and Hedging – Contracts in an Entity’s Own Stock In connection with the issuance of the March 30, 2020 and April 23, 2020 Notes, in March and April 2020, on the initial measurement dates, the fair values of the embedded conversion option derivatives of $245,918 was recorded as a derivative liability and was allocated as a debt discount up to the net proceeds of the Notes of $85,502, with the remainder of $160,416 charged to current period operations as initial derivative expense. During the year ended December 31, 2020, at the end of each period and upon conversion or repayment, the Company revalued the embedded conversion option derivative liabilities and recorded a derivative gain of $69,793. In connection with the revaluation and the initial derivative expense, the Company recorded an aggregate derivative expense of $90,623 during the year ended December 31, 2020. In connection with the warrants issued in connection with the September and December 2019 SPAs, the March 2020 SPA, the April 2020 SPA, the Company determined that the terms of the warrants contain terms that are fixed monetary amounts at inception and, accordingly, the warrants were not considered derivatives. The fair value of the warrants was determined using the Binomial valuation model. In connection with the issuance of the March 2020 and April 2020 warrants, on the initial measurement date, the relative fair value of the warrants of $14,498 was recorded as a debt discount and an increase in paid-in capital. During the years ended December 31, 2020, the fair value of the derivative liabilities and warrants was estimated using the Binomial valuation model with the following assumptions: 2020 Dividend rate — Term (in years) 0.25 to 5.00 years Volatility 293.4% to 345.7 % Risk—free interest rate 0.12% to 0.39 % During the year ended December 31, 2020, the Company issued 37,171,800 shares of its common stock upon the conversion of principal of $152,285, accrued interest of $36,244 and fees of $2,500. Additionally, the Company repaid principal of $393,215 and accrued interest of $15,917. Upon conversion, exercise or repayment, the respective derivative liabilities were marked to fair value at the conversion, repayment or exercise date and then the related fair value amount of $1,066,535 was reclassified to other income as part of gain or loss on extinguishment. Additionally, in 2020, upon repayment, the Company and Investor agreed to cancel 288,750 warrants and agreed to modify the exercise price of the remaining warrants to $0.01 per share (see Note 10 - warrants). Since the fair value of the warrants using the new exercise price was less than the initial fair value amount, no additional expense was recorded (see Note 10 – warrants). As of December 31, 2020, all of these convertible notes were either converted or repaid resulting in a zero balance. For the year ended December 31, 2020, interest expense related to convertible notes and warrants amounted to $551,100, including amortization of debt discount and debt premium charged to interest expense of $409,668. 2021 On October 15, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”), pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000 (the “Initial Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s common stock at an exercise price of $0.05 per share, an amount equal to 50% of the conversion shares to be issued (the “Initial Warrants”). The Company received net proceeds of $680,000, which is net of original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000. The transactions contemplated under the SPA closed on October 18, 2021. Pursuant to the SPA, the Investor has agreed to purchase an additional $825,000 10% Original Issue Discount Senior Convertible Promissory Note (the “Second Note,” and together with the Initial Note, the “Notes”), and a five-year warrant (the “Second Warrant,” and together with the Initial Warrant, the “Warrants”) to purchase, in the aggregate, shares of the Company’s common stock at an exercise price of $0.05 per share from the Company in an amount equal to 50% of the conversion shares to be issued upon the same terms as the Initial Note and Initial Warrant (subject to there being no event of default under the Initial Note or other customary closing conditions), within three trading days of a registration statement registering the shares of the Company’s common stock issuable under the Notes (the “Conversion Shares”) and upon exercise of the Warrants (the “Warrant Shares”) being declared effective by the SEC. The Note matures 12 months after issuance, bears interest at a rate of 4% per annum, and is initially convertible beginning on the six month anniversary of the original issue date into the Company’s common stock at a fixed conversion price of $0.025 per share, subject to adjustment for stock splits, stock combinations, dilutive issuances, and similar events, as described in the Note. If the average Closing Price during any 10 consecutive Trading Day period beginning and ending during the 60 Day Effectiveness Period (the “Average Closing Price”) is below the Conversion Price than the conversion price shall be reduced to such Average Closing Price but in no event less than $0.0175. The “60 Day Effectiveness Period” means the 60 calendar days beginning on the day the Registration Statement filed in connection with the Registration Rights Agreement covering the respective Tranche is first declared effective by the SEC. The Note may be prepaid at any time for the first 90 days at face value plus accrued interest. From day 91 through day 180, the Note may be prepaid in an amount equal to 110% of the principal amount plus accrued interest. From day 181 through the day immediately preceding the maturity date, the Note may be prepaid in an amount equal to 120% of the principal amount plus accrued interest. The Note and Warrants contain conversion limitations providing that a holder thereof may not convert the Notes or exercise the Warrants to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. At any time this Note or any amounts accrued and payable thereunder remain outstanding, the Company or any Subsidiary, as applicable, sells or grants any option to purchase or sells or grants any right to reprice, or otherwise disposes of or issues (or announces any sale, grant or any option to purchase or other disposition), any common stock or common stock equivalents entitling any Person to acquire shares of the Company’s common stock at an effective price per share that is lower than the conversion price then in effect (such lower price, the “Base Conversion Price” and each such issuance or announcement a “Dilutive Issuance”), then the conversion price shall be immediately reduced to equal the Base Conversion Price. Such adjustment shall be made whenever such common stock or common stock equivalents are issued. In connection with the SPA, the Company entered into a Registration Rights Agreement dated October 15, 2021 (the “Registration Rights Agreement”), with the Investor pursuant to which it is obligated to file a registration statement with the SEC within 45 days after the date of the agreement to register the resale by the Investor of the conversion shares and warrant shares, and use all commercially reasonable efforts to have the registration statement declared effective by the SEC within 60 days after the registration statement is filed. Upon the occurrence of an event of default under the Notes, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum. Events of default included, among other things, (i) any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days; (ii) the Company or any Subsidiary shall be subject to a Bankruptcy Event; (iii) the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor; (iv) the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction); (v) the Company incurs any Indebtedness other than Permitted Indebtedness; (vi) the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day; The Company has also granted the Investor a 12-month (or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%. In connection with the SPA, on October 18, 2021, the Company issued 668,151 shares of its common stock to the placement agent as fee for the capital raise. The 668,151 shares of common stock issued were recorded as a debt discount of $14,064 based on the relative fair value method to be amortized over the life of the Note. The 16,500,000 Initial Warrants were valued at $347,142 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note. The original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000, aggregating $145,000, have been recorded as a debt discount to be amortized into interest expense over the twelve-month term of the note. The Initial Note was convertible into common shares at an initial conversion price of is $0.025 which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Additionally, as warrants and common shares were issued with the Initial Note, the proceeds were allocated to the instrument based on relative fair value. The Initial Warrants did not contain any features requiring liability treatment and therefore were classified as equity. The value allocated to the Initial Warrants and common shares issued was $347,142 and $14,064, respectively, and $318,794 was allocated to the beneficial conversion feature. Since the intrinsic value of the beneficial conversion feature, warrants and common shares was greater than the proceeds allocated to the convertible instrument, the amount of the discount assigned to the beneficial conversion feature, warrants and common shares issued was limited to the amount of the proceeds allocated to the convertible instrument. Accordingly, the Company recorded an aggregate non-cash debt discount of $680,000 with the credit to additional paid in capital. The debt discount associated shall be amortized to interest expense over the term of the Convertible Note. For the year ended December 31, 2021, amortization of debt discounts related to this convertible note payable amounted to $171,875 which has been included in interest expense on the accompanying consolidated statements of operations. On December 31, 2021, accrued interest payable under this Convertible Note amounted to $7,052 and is included in accrued expenses on the accompanying consolidated statement of operations. The Company uses the Binomial Valuation Model to determine the fair value of its stock warrants which requires the Company to make several key judgments including: ● the value of the Company’s common stock; ● the expected life of issued stock warrants; ● the expected volatility of the Company’s stock price; ● the expected dividend yield to be realized over the life of the stock warrants; and ● the risk-free interest rate over the expected life of the stock warrants. The Company’s computation of the expected life of issued stock warrants was based on the simplified method as the Company does not have adequate exercise experience to determine the expected term. The interest rate was based on the U.S. Treasury yield curve in effect at the time of grant. The computation of volatility was based on the historical volatility of the Company’s common stock. On October 18, 2021, the fair value of the stock warrants was estimated at issuance using the Binomial Valuation Model with the following assumptions: Dividend rate — % Term (in years) 5 years Volatility 348.5 % Risk—free interest rate 1.16 % On December 31, 2021 and 2020, convertible notes payable consisted of the following: December 31, December 31, Convertible note payable $ 825,000 $ - Less: unamortized debt discount (653,125 ) - Convertible note payable, net 171,875 - Less: current portion of convertible note payable (171,875 ) - Convertible note payable – long-term $ - $ -

Notes Payable

Notes Payable	12 Months Ended
	Dec. 31, 2021
Notes Payable Disclosure [Abstract]
NOTES PAYABLE	NOTE 9 – NOTES PAYABLE On December 31, 2021 and 2020, notes payable consisted of the following: December 31, December 31, Notes payable $ 978,925 $ 400,000 Note payable – PPP note 48,929 156,200 Total notes payable 1,027,854 556,200 Less: current portion of notes payable (488,414 ) (521,138 ) Notes payable – long-term $ 539,440 $ 35,062 Notes Payable On November 14, 2018, the Company entered into a Revolving Credit Facility Loan and Security Agreement (“Loan Agreement”) and a Secured Promissory Note (the “Note”) with BOCO Investments, LLC (the “Lender”). Subject to and in accordance with the terms and conditions of the Loan Agreement and the Note, the Lender agreed to lend to the Company up to $400,000 (the “Maximum Loan Amount”) against the issuance and delivery by the Company of the Note for use as working capital and to assist in inventory acquisition. In 2018, the Lender loaned $400,000 to the Company, the Maximum Loan Amount. The Company should have repaid all principal, interest and other amounts outstanding on or before November 14, 2020. The Company’s obligations under the Loan Agreement and the Note are secured by a first-priority security interest in substantially all of the Company’s assets (the “Collateral”). The outstanding principal advanced to Company pursuant to the Loan Agreement initially bore interest at the rate of 12% per annum, compounded annually. Upon the occurrence of an Event of Default under the Loan Agreement and Note, all amounts then outstanding (including principal and interest) shall bear interest at the rate of 18% per annum, compounded annually until the Event of Default is cured. Additionally, at or prior to December 31, 2018, the Company should have achieved an accounts receivable balance plus inventory equal to the unpaid principal balance of the Note (the “Minimum Asset Amount”). In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018 , Commencing on January 10, 2019 and on or before the l0th day of each month thereafter, the Company should have paid Lender all interest accrued on outstanding principal under the Loan Agreement and Notes as of the end of the month then concluded. Upon the occurrence of any Event of Default and at any time thereafter, Lender may, at its option, declare any and all obligations immediately due and payable without demand or notice. As of September 30, 2021 and December 31, 2020, the Company did not meet the Minimum Asset Amount covenant as defined in the Loan Agreement, failed to timely pay interest payments due, and has violated other default provisions. The note balance due of $400,000 has been reflected as a current liability on the accompanying consolidated balance sheets and interest shall accrue at 18% per annum. The Loan Agreement and Note contain customary representations, warranties, and covenants, including certain restrictions on the Company’s ability to incur additional debt or create liens on its property. The Loan Agreement and the Note also provide for certain events of default, including, among other things, payment defaults, breaches of representations and warranties, breach of covenants, and bankruptcy or insolvency proceedings, the occurrence of which, after any applicable cure period, would permit Lender, among other things, to accelerate payment of all amounts outstanding under the Loan Agreement and the Note, as applicable, and to exercise its remedies with respect to the Collateral, including the sale of the Collateral. On December 31, 2021 and 2020, principal amount due under this Note amounted to $400,000 and is considered to be in default. On December 31, 2021 and 2020, accrued interest payable under this Note amounted to $220,241 and $148,241, respectively, and is included in accrued expenses on the accompanying consolidated statement of operations. On May 10, 2021, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) and a Secured Promissory Note (the “Promissory Note”) in the amount of $500,000 with a lender. The Promissory Note shall accrue interest at 8% per annum, compounded annually, and all outstanding principal and accrued interest is due and payable of May 10, 2023. The Company’s obligations under the Loan Agreement and the Promissory Note are secured by a second priority security interest in substantially all of the Company’s assets (the “Collateral”). The Loan Agreement and Promissory Note contain customary representations, warranties, and covenants, including certain restrictions on the Company’s ability to incur additional debt or create liens on its property. The Loan Agreement and the Promissory Note also provide for certain events of default, including, among other things, payment defaults, breaches of representations and warranties and bankruptcy or insolvency proceedings, the occurrence of which, after any applicable cure period, would permit Lender, among other things, to accelerate payment of all amounts outstanding under the Loan Agreement and the Promissory Note, as applicable, and to exercise its remedies with respect to the Collateral. Upon the occurrence of an Event of Default under the Loan Agreement and Promissory Note, all amounts then outstanding (including principal and interest) shall bear interest at the rate of 18% per annum, compounded annually until the Event of Default is cured. On December 31, 2021, accrued interest payable under this Promissory Note amounted to $25,863 and is included in accrued expenses on the accompanying consolidated statement of operations. On December 31, 2021 and 2020, principal amount due under this Promissory Note amounted to $500,000 and $0, respectively. On July 22, 2021, in connection with the acquisition of Mobile Tint, the Company assumed vehicle and equipment loans in the amount of $95,013. These loans bear interest at rates ranging from 6.79% to 8.24% and are payable monthly through April 2025. On December 31, 2021, notes payable related to these vehicles amounted to $78,925. PPP Loan On April 28, 2020, the Company entered into a Paycheck Protection Program Promissory Note (the “PPP Note”) with respect to a loan of $156,200 (the “PPP Loan”) from Comerica Bank. The PPP Loan was obtained pursuant to the Paycheck Protection Program (the “PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES act”) administered by the U.S. Small Business Administration (“SBA”). The PPP Loan matures on April 28, 2022 and bears interest at a rate of 1.00% per annum. The PPP Loan is payable in 18 equal monthly payments of approximately $8,900 commencing November 1, 2020. The PPP Loan may be prepaid at any time prior to maturity with no prepayment penalties. The Company may apply to have the loan forgiven pursuant to the terms of the PPP if certain criteria are met. The Company applied for forgiveness of its PPP Loan, and on November 4, 2021, the Company was notified that the Small Business Administration forgave $95,000 of the principal loan amount and $1,442 of interest. As of November 4, 2021, the remaining principal balance of the loan is $61,200 and the remaining accrued interest balance is $935. During the year ended December 31, 2021, the Company repaid PPP Loan principal of $12,271. On December 31, 2021 and 2020, the principal amount due under the PPP Loan amounted to $48,929 and $156,200, respectively. As of December 31, 2021 and 2020, accrued interest payable amounted to $1,031 and $1,061, respectively. For the years ended December 31, 2021 and 2020, interest expense related to this PPP Loan amounted to $1,411 and $1,061, respectively. On December 31, 2021, future annual maturities of notes payable are as follows: December 31, Amount 2022 $ 488,414 2023 530,720 2024 6,458 2025 2,262 Total notes payable on December 31, 2021 $ 1,027,854

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
SHAREHOLDERS' DEFICIT	NOTE 10 – SHAREHOLDERS’ DEFICIT Preferred Stock Series A Preferred stock On October 16, 2019, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series A Convertible Preferred Stock, with the Secretary of State of the State of Colorado. The Certificate of Designation established 800,000 shares of the Series A Preferred Stock, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations, Preferences, Rights, and Limitations of Series A Convertible Preferred Stock (“Certificate of Designations”) provides that the Series A Convertible Preferred Stock shall have no right to vote on any matters on which the common shareholders are permitted to vote. The Series A Convertible Preferred Stock ranks senior with respect to dividends and right of liquidation to the Company’s common stock and junior with respect to dividends and right of liquidation to all existing and future indebtedness of the Company and existing and outstanding preferred stock of the Company. Each share of Series A Preferred Stock shall have a stated value of $1.00 (the “Stated Value”). Each share of Series A Preferred Stock carried an annual dividend in the amount of 4% of the Stated Value (the “Dividend Rate”), which shall be cumulative and compounded daily, payable solely upon redemption, liquidation or conversion. Upon the occurrence of an Event of Default, the Dividend Rate shall automatically increase to 22%. At any time during the periods set forth on the table immediately following this paragraph (the “Redemption Periods”) provided that an Event of Default has not occurred, the Company had the right, at the Company’s option, to redeem all or any portion of the shares of Series A Preferred Stock for an amount equal to (i) the total number of Series A Preferred Stock held by the applicable Holder multiplied by (ii) the Stated Value plus the Adjustment Amount, (the “Optional Redemption Amount”). The Adjustment Amount shall equal to any accrued but unpaid dividends, the default adjustment amounts, as defined in the Certificate of Designation, if applicable, failure to deliver fees, if any, and any other fees as set forth in the Certificate of Designation. After the expiration of 180 days following the Issuance Date of the applicable shares of Series A Preferred Stock, the Company had no right of redemption. Redemption Period Redemption 1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date. 100% 2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date. 107% 3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date. 112% 4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date. 117% 5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date. 120% On the earlier to occur of (i) the date which is eighteen months following the Issuance Date and (ii) the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series A Preferred Stock of the Holders (which have not been previously redeemed or converted). Within five days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to (i) the total number of Series A Preferred Stock held by such Holder multiplied by (ii) the Stated Value plus the Adjustment Amount. The Holder of Series A Preferred stock had the right from time to time, and at any time during the period beginning on the date which is 180 days following the issuance date, to convert all or any part of the outstanding Series A Preferred Stock into the Company’s common stock. The conversion price (the “Conversion Price”) shall equal the Variable Conversion Price (as defined below) (subject to equitable adjustments by the Company relating to the Company’s securities or the securities of any subsidiary of the Company, combinations, recapitalization, reclassifications, extraordinary distributions and similar events). The “Variable Conversion Price” shall mean 81% multiplied by the Market Price (as defined below) (representing a discount rate of 19%). “Market Price” means the average of the two lowest Trading Prices for the common stock during the ten Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. “Trading Price” means, for any security as of any date, the closing bid price on the applicable trading market as reported by a reliable reporting service designated by the Holder. “Trading Day” shall mean any day on which the Common Stock is tradable for any period on the OTC, or on the principal securities exchange or other securities market on which the common stock is then being traded. The Company accounted for the Series A Preferred Stock as stock settled debt under ASC 480 due to mandatory redemption and during the year ended December 31, 2020, the Company recorded an aggregate debt premium of $42,553 with a charge to interest expense. During the year ended December 31, 2020, the Company entered into Series A Preferred Stock Purchase Agreements with an accredited investor whereby the investor agreed to purchase an aggregate of 154,800 unregistered shares of the Company’s Series A Preferred stock, par value $0.10 for $129,000, or $0.833 per share. During the year ended December 31, 2020, the Company received cash proceeds of $120,000, net of fees of $9,000. This discount of $9,000 was recognized and was amortized to interest expense over the redemption terms of the Series A preferred shares or the date that the debt is convertible into common shares, whichever is shorter. For the year ended December 31, 2020, amortization of discount charged to interest expense amounted to $14,333. During the year ended December 31, 2020, the Company accrued a dividend payable of $4,852 which was included in interest expense on the accompanying consolidated statement of operations. As of December 31, 2020, the Company had paid or converted into common stock all accrued dividends due. During the year ended December 31, 2020, the Company issued 16,132,701 shares its common stock upon the conversion of 211,200 shares of Series A preferred with a stated redemption value of $211,200 and related accrued dividends payable of $4,224. The conversion price was based on contractual terms of the related Series A preferred shares. Upon conversion, the Company reclassified put premium of $49,543 to paid-in capital. Additionally, on August 24, 2020, the Company settled with the investor and redeemed the remaining 103,200 Series A preferred shares for a cash payment of $117,047 which included the redemption of stated value of $103,200, accrued dividends of $1,562, and a redemption penalty of $12,285 which was included in interest expense on the accompanying consolidated statement of operations. Additionally, upon repayment, the Company wrote off the remaining put premium balance of $24,207 and recorded a gain on extinguishment of $24,207. On August 24, 2020, the Company filed a Certificate of Elimination with the State of Colorado to eliminate the Series A preferred stock. The Company classified the Series A Preferred Stock as a liability in accordance with ASC Topic No. 480, “ Distinguishing from Equity As of December 31, 2020, the net Series A Preferred Stock balance was $0 and fully redeemed. The Company recognized interest expense on the Series A Preferred Stock of $126,423 for the year ended December 31, 2020, which includes accretion expense, put premium on stock-settled debt, accrued dividends, amortization of offering costs and redemption penalties paid . Series B Preferred Stock On December 12, 2019, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series B Convertible Preferred Stock (the “Series B”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series B, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing. The Series B ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series B has a stated value per share of $1,000, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value. The Series B is subject to redemption (at Stated Value, plus any accrued, but unpaid dividends (the “Liquidation Value”) by the Company no later than three years after a Deemed Liquidation Event and at the Company’s option after one year from the issuance date of the Series B, subject to a ten-day notice (to allow holder conversion). A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”). In the event of a conversion of any Series B, the Company shall issue to the holder a number of shares of common stock equal to the sum of the Stated Value plus accrued but unpaid dividends multiplied by the number of shares of Series B Preferred Stock being converted divided by the Conversion Price. Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series B but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series B, the holders of Series B will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series B equal to the Liquidation Value. The Series B has voting rights per Series B Share equal to the Liquidation Value per share, divided by the Conversion Price, multiplied by fifty (50). Subject to applicable Colorado law, the holders of Series B will have functional voting control in situations requiring shareholder vote. These Series B preferred share issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the issuer, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series B preferred stock agreements, Series B preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series B preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series B preferred stock is classified as temporary equity. The Company concluded that the Series B Preferred Stock represented an equity host and, therefore, the redemption feature of the Series B Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series B Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series B Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. On December 12, 2019, the Board of Directors of the Company agreed to satisfy $108,000 of accrued compensation owed to its directors and executive officers (collectively, the “Management”) through a Liability Reduction Plan (the “Plan”). Under this Plan, Management agreed to accept 108 shares of the Company’s Series B convertible preferred stock in settlement of accrued compensation. On December 21, 2020, the Board of Directors of the Company agreed to satisfy $318,970 of accrued compensation owed to its directors and executive officers (collectively, the “Management”) through a Liability Reduction Plan (the “Plan”). Under this Plan, Management agreed to accept 319 shares of the Company’s Series B convertible preferred stock in settlement of accrued compensation. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, during the year ended December 31, 2020, the Company immediately recorded non-cash stock-based compensation of $1,048,143 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. This non-cash stock-based compensation increased the Company’s net loss attributable to common stockholders and net loss per share. On January 18, 2021, the Board of Directors of the Company agreed to satisfy $295,000 of accrued compensation owed to its executive officers and former executive officer (collectively, the “Management”) through a Liability Reduction Plan (the “Plan”). Under this Plan, Management agreed to accept 295 shares of the Company’s Series B convertible preferred stock in settlement of accrued compensation. The conversion feature of the Series B Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series B Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded non-cash stock-based compensation of $3,778,810 related to the beneficial conversion feature arising from the issuance of Series B Preferred Stock. 158 Series B Preferred Stock vested on May 1, 2021 and 564 Series B Preferred Stock shall vest on May 1, 2022. During the year ended December 31, 2021 and 2020, the Company accrued a dividend payable of $14,165 and $2,476, respectively, which was included in preferred stock dividends on the accompanying consolidated statement of shareholders’ deficit. As of December 31, 2021, the net Series B Preferred Stock balance was $738,611 which includes stated value of $721,970 and accrued dividends payable of $16,641. As of December 31, 2020, the net Series B Preferred Stock balance was $429,446 which includes stated value of $426,970 and accrued dividends payable of $2,476. Series C Preferred Stock On August 20, 2020, the Company filed an Amendment to its Articles of Incorporation to designate a series of preferred stock, the Series C Convertible Preferred Stock (the “Series C”), with the Secretary of State of the State of Colorado. The Certificate of Designations established 100,000 shares of the Series C, par value $0.10, having such designations, preferences, and rights as determined by the Company’s Board of Directors in its sole discretion, in accordance with the Company’s Articles of Incorporation and Amended and Restated Bylaws. The Certificate of Designations became effective with the State of Colorado upon filing. The Series C ranks senior with respect to dividends and right of liquidation with the Company’s common stock and junior to all existing and future indebtedness of the Company. The Series C has a stated value per share of $100, subject to adjustment as provided in the Certificate of Designations (the “Stated Value”), and a dividend rate of 2% per annum of the Stated Value. The Company has no option to redeem the Series C Preferred Stock. If the Company determines to liquidate, dissolve or wind-up its business and affairs, or effect any Deemed Liquidation Event as defined below, each of which has been approved by the holders of a majority of the shares of Series C Preferred Stock then outstanding, the Company will redeem all of the shares of Series C Preferred Stock outstanding immediately prior to such mandatory redemption event at a price per share of Series C Preferred Stock equal to the aggregate Series C Liquidation Value, which is 150% of the sum of the Stated Value plus accrued and unpaid dividends, for the shares of Series C Preferred Stock being redeemed. The Company will deliver ten-day advance written notice prior to the consummation of any mandatory redemption event via email or overnight courier (“Notice of Mandatory Redemption”) to each Holder whose shares are to be redeemed. The Series C is subject to redemption at liquidation Value noted above by the Company. Upon receipt by any Holder of a Notice of Mandatory Redemption, if Holder does not choose to convert, such Holder will promptly submit to the Company such Holder’s Series C Preferred Stock certificates on the Redemption Payment Date. Upon receipt of such Holder’s Series C Preferred Stock certificates, the Company will pay the applicable redemption price to such Holder in cash. A “Deemed Liquidation Event” will mean: (a) a merger or consolidation in which the Company is a constituent party or a subsidiary of the Company is a constituent party and the Company issues shares of its capital stock pursuant to such merger or consolidation, except any such merger or consolidation involving the Company or a subsidiary in which the shares of capital stock of the Company outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power, of the capital stock of the surviving or resulting corporation or, if the surviving or resulting corporation is a wholly-owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or (b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company. Since the Company has determined that a deemed liquidation event is not probable, the Series C is stated at the Stated Value plus accrued and unpaid dividends rather than redemption value, which is liquidation value. The Series C is convertible at the option of a holder at any time following the issuance date. In the event of a conversion of any Series C Preferred Stock, the Company shall issue to such Holder a number of Conversion Shares equal to (x) the sum of (1) the Stated Value per share of Series C Preferred Stock plus (2) any accrued but unpaid dividends thereon multiplied by (y) the number of shares of Series C Preferred Stock held by such Holder and subject to the Holder Conversion Notice, divided by (z) the Conversion Price with respect to such Series C Preferred Stock. Conversion Price means a price per share of the common stock equal to the lowest daily volume weighted average price of the common stock for any trading day during the two years preceding the date of delivery of the conversion notice, subject to adjustment as otherwise provided in the Series C Certificate of Designation. Upon liquidation of the Company after payment or provision for payment of liabilities of the Company and after payment or provision for any liquidation preference payable to the holders of any preferred stock ranking senior to the Series C but prior to any distribution to the holders of Common Stock or preferred stock ranking junior upon liquidation to the Series C, the holders of Series C will be entitled to be paid out of the assets of the Company available for distribution to its stockholders an amount with respect to each share of Series C equal to the Liquidation Value. Through April 28, 2021, each share of Series C Preferred Stock was entitled to vote on all matters requiring shareholder vote. Each share of Series C Preferred Stock was entitled to the number of votes per share based on the calculation of the number of conversion shares of Series C Preferred Stock is then convertible. On April 28, 2021, the Company filed an Amended and Restated Certificate of Designations of Preferences, Rights, and Limitations of Series C Convertible Preferred Stock (the “Amended Certificate”). The Amended Certificate changed the voting rights of the Series C Preferred Stock on any matters requiring shareholder approval or any matters on which the common shareholders are permitted to vote. Series C Preferred Stock shall have no right to vote on any matters requiring shareholder approval or any matters on which the common shareholders (or other preferred stock of the Company which may vote with the common shareholders) are permitted to vote. With respect to any voting rights of the Series C Preferred Stock set forth herein, the Series C Preferred Stock shall vote as a class, each share of Series C Preferred Stock shall have one vote on any such matter, and any such approval may be given via a written consent in lieu of a meeting of the Holders of the Series C Preferred Stock. Any reference herein to a determination, decision or election being made by the “Majority Holders” shall mean the determination, decision or election as made by Holders holding a majority of the issued and outstanding shares of Series C Preferred Stock at such time. It also adjusts the conversion feature of the Series C Preferred Stock so that any Holder of Series C Preferred Stock cannot convert any portion of the Series C in excess of that number of Series C Preferred Stock that upon conversion would result in beneficial ownership by the Holder of more than 4.99% of the outstanding shares of common stock of the Company. These Series C preferred stock issuances with redemption provisions that permit the issuer to settle in either cash or common stock, at the option of the holder, were evaluated to determine whether temporary or permanent equity classification on the consolidated balance sheet was appropriate. As per the terms of the Series C preferred stock agreements, Series C preferred stock is redeemable for cash and other assets on the occurrence of a deemed liquidation event. A deemed liquidation event includes a change of control which is not in the Company’s control. As such, since Series C preferred stock is redeemable upon the occurrence of an event that is not within the Company’s control, the Series C preferred stock is classified as temporary equity. The Company concluded that the Series C Preferred Stock represented an equity host and, therefore, the redemption feature of the Series C Preferred Stock was not considered to be clearly and closely related to the associated equity host instrument. However, the redemption features did not meet the net settlement criteria of a derivative and, therefore, were not considered embedded derivatives that required bifurcation. The Company also concluded that the conversion rights under the Series C Preferred Stock were clearly and closely related to the equity host instrument. Accordingly, the conversion rights feature on the Series C Preferred Stock were not considered an embedded derivative that required bifurcation. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. During August and September 2020, the Company entered into subscription agreements with an accredited investor whereby the investor agreed to purchase an aggregate of purchase 6,300 shares of the Company’s Series C Convertible Preferred Stock for $630,000, or $100.00 per share (the “Stated Value”), which were used to pay off various discounted convertible instruments and redeem Series A preferred stock. During the three months ended December 31, 2020, the Company entered into subscription agreements with an accredited investor whereby the investor agreed to purchase an aggregate of purchase 7,000 shares of the Company’s Series C Convertible Preferred Stock for $700,000, or $100.00 per share (the “Stated Value”), which were used from working capital purposes. Because the Series C Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, during the year ended December 31, 2020, the Company immediately recorded a non-cash deemed dividend of $1,525,873 related to the beneficial conversion feature arising from the issuance of Series C Preferred Stock. This non-cash deemed dividend increased the Company’s net loss attributable to common stockholders and net loss per share. On February 24, 2021, the Company entered into a subscription agreement with an accredited investor whereby the investor agreed to purchase 2,500 shares of the Company’s Series C Convertible Preferred Stock for $250,000, or $100.00 per share, the stated value, which was used for working capital purposes. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series C Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded a non-cash deemed dividend of $2,845,238 related to the beneficial conversion feature arising from the issuance of Series C Preferred Stock. This non-cash deemed dividend increased the Company’s net loss attributable to common stockholders and net loss per share. On August 25, 2021, the Company entered into a subscription agreement with an accredited investor whereby the investor agreed to purchase 3,000 shares of the Company’s Series C Convertible Preferred Stock for $300,000, or $100.00 per share, the stated value, which was used for working capital purposes. The conversion feature of the Series C Preferred Stock at the time of issuance was determined to be beneficial on the commitment date. Because the Series C Preferred Stock was perpetual with no stated maturity date, and the conversions could occur any time from the date of issuance, the Company immediately recorded a non-cash deemed dividend of $1,509,523 related to the beneficial conversion feature arising from the issuance of Series C Preferred Stock. This non-cash deemed dividend increased the Company’s net loss attributable to common stockholders and net loss per share. During the year ended December 31, 2021 and 2020, the Company accrued a dividend payable of $32,981 and $6,031, respectively, which was included in preferred stock dividends on the accompanying consolidated statements of shareholders’ deficit. On December 7, 2021, the Company issued 1,500,000 shares of its common stock upon conversion of 120 shares of Series C Preferred Stock with a stated value of $12,000. As of December 31, 2021, the net Series C Preferred Stock balance was $1,907,012 which includes stated liquidation value of $1,868,000 and accrued dividends payable of $39,012. As of December 31, 2020, the net Series C Preferred Stock balance was $1,336,031 which includes stated value of $1,330,000 and accrued dividends payable of $6,031. Common Stock Sale of Common Stock In connection with subscription agreements dated January 13, 2020 and February 18, 2020, the Company received cash proceeds of $280,000 from an investor for the purchase of 7,000,000 shares of the Company’s common stock at $0.04 per share. In connection with subscription agreements dated May 8, 2020, the Company received cash proceeds of $161,000 from an investor for the purchase of 7,000,000 shares of the Company’s common stock at $0.023 per share. In connection with subscription agreements dated July 2, 2020, the Company received cash proceeds of $280,000 from investors for the purchase of 21,538,462 shares of the Company’s common stock at $0.013 per share. In connection with a subscription agreement dated December 31, 2020, the Company received cash proceeds of $100,000 from an investor for the purchase of 1,851,852 shares of the Company’s common stock at $0.054 per share. Issuance of Common Stock for Services Issuance of Common Stock for Professional Fees On February 20, 2020 and effective March 1, 2020, the Company entered into a six-month consulting agreement with an entity for investor relations services. In connection with this consulting agreement, the Company issued 1,250,000 restricted common shares of the Company to the consultant. These shares vest immediately. These shares were valued at $50,000, or $0.04 per common share, based on contemporaneous common share sales by the Company. In connection with this consulting agreement, as of September 30, 2020, the Company recorded stock-based professional fees of $50,000. On March 31, 2020 and effective April 1, 2020, the Company entered into two one-year advisory board agreements with two individuals for services to be rendered on the Company’s medical advisory board. In connection with these advisory board agreements, the Company issued an aggregate of 500,000 restricted common shares of the Company to these advisory board members. These shares vest on April 1, 2021. These shares were valued at $20,000, or $0.04 per common share, based on contemporaneous common share sales by the Company. In connection with this consulting agreement, during the years ended December 31, 2021 and 2020, accretion of stock-based consulting fees amounted to $5,000 and $15,000, respectively. On July 1, 2020, the Company entered into a six-month consulting agreement with an entity for investor relati

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 11 – COMMITMENTS AND CONTINGENCIES Legal Matters From time to time, the Company may be involved in litigation related to claims arising out of its operations in the normal course of business. As of December 31, 2021, other than discussed below, the Company is not involved in any other pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations, or cash flows. On January 20, 2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition. On March 8, 2021, a former officer of the Company resigned. Both parties alleged certain claims against the other, including certain compensation claims, and are in discussion regarding resolution. Neither party has filed litigation. The Company intends to vigorously defend itself against any possible claims and assert any relevant claims against the former executive and believes it will prevail. In July 2021, a former employee of the Company filed a small claims case for approximately $16,000 in Harris County, TX, and the Company filed its response on August 2021. There has been no further communication from the Court. The Company intends to vigorously defend itself against the claim made and believes it will prevail. As of December 31, 2021, the Company has accrued compensation of $18,250 to this former employee which is included in accrued compensation on the accompanying consolidated balance sheet. Employment Agreements On October 18, 2017, the Company entered into an employment agreement with Mr. Scott Silverman, pursuant to which he serves as the Chief Executive Officer of the Company for an initial term of three years that extends for successive one-year renewal terms unless either party gives 30-days’ advance notice of non-renewal. As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits: ● An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward. ● After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company. ● Annual cash performance bonus opportunity as determined by the Board. ● An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives. ● Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits. The April 25, 2018 financing received of $1,240,000 triggered the right of the employee to receive the deferred salary and the 5% bonus provision disclosed above. Mr. Silverman’s employment agreement provides that, in the event that his employment is terminated by the Company without “cause” (as defined in his employment agreement), or if Mr. Silverman resigned for “good reasons” (as defined in his new employment agreement), subject to a complete release of claims, he will be entitled to (i) retain all stock options previously granted; and (ii) receive any benefits then owed or accrued along with one year of base salary and any unreimbursed expenses incurred by him. All amounts shall be paid on the termination date. In the event that Mr. Silverman’s employment is terminated by the Company for “cause” (as defined in his employment agreement), or if Mr. Silverman resigned without “good reasons” (as defined in his employment agreement), subject to a complete release of claims, he will be entitled to receive any unpaid base salary and benefits then owed or accrued and any unreimbursed expenses incurred by him. Additionally, if a change of control (as defined in his employment agreement) occurs during the term of this agreement, all unvested stock options will vest in full and if the valuation of the Company in the change of control transaction is greater than $0.85 per common share, then Mr. Silverman shall be paid a bonus equal to two times his minimum base salary and minimum target bonus. Pursuant to the employment agreement, Mr. Silverman will be subject to a confidentiality covenant, a two-year post-termination non-competition covenant and a two-year post-termination non-solicitation covenant. On June 30, 2020, the Company amended the employment agreement of Mr. Silverman to provide for successive one-year extensions until either the executive or the Board of Directors of the Company gives notice to terminate the employment agreement per its terms. This employment agreement amendment also includes an allowance of up to $10,000 per year to cover uncovered medical/dental expenses for Mr. Silverman and his family. On January 18, 2021, the Company’s board of directors approved a bonus to officers and an employee of the Company in the aggregate amount of $330,000 which deferred and recorded as accrued compensation on the bonus approval date. On July 21, 2021, the Company entered into the Employment Agreement with Mr. Wanke, the President of Mobile, to serve as the President of C-Bond’s Safety Solutions Group. Under the three-year Employment Agreement, Mr. Wanke will receive a base salary of $240,000 per year, which may be increased from time to time with the approval of the board of directors. In addition, Mr. Wanke may receive an annual bonus as determined by the board of directors. It is understood that although Mr. Wanke’s base salary will be paid by Mobile, 50% of the base salary will be allocated to the expenses of Mobile, and the other 50% of the base salary will be allocated to the expenses of the Company. The term of this Agreement (the “Initial Term”) shall begin as of July 21, 2021 (the “Effective Date”) and shall end on the earlier of (i) the third anniversary of the Effective Date and (ii) the time of the termination of the Executive’s employment in accordance with the Employment Agreement. This Initial Term and any Renewal Term (as defined below) shall automatically be extended for one or more additional terms of one (1) year each (each a “Renewal Term” and together with the Initial Term, the “Term”), unless either the Company or Executive provide notice to the other Party of their desire to not so renew the Initial Term or Renewal Term (as applicable) at least thirty (30) days prior to the expiration of the then-current Initial Term or Renewal Term, as applicable. All unvested shares of stock and stock options shall expire upon such termination, if any. The Executive shall be eligible for an annual bonus payment in an amount to be determined by the Board of Directors of the Company (the “Bonus”). The Bonus shall be determined and payable based on the achievement of certain performance objectives of the Company as established by the Board and communicated to and agreed to by the Executive in writing as soon as practicable after commencement of the year in respect of which the Bonus is paid. The Bonus, if earned, is payable in cash and/or restricted stock at the discretion of the Board. It is understood between the Parties that the target bonus for each year shall be up to 50% of the Base Salary. On December 8, 2021, the Company’s board of directors approved a bonus to certain officers in the aggregate amount of $309,615 which is equal to 50% of their annual compensation. This bonus will be paid 10% in cash ($30,962) which was paid in December 2021 and 90% in equity amounting $278,653 which as of December 31, 2021 has been accrued and included in accrued compensation on the accompanying consolidated balance sheet. On January 6, 2022, the Board of Directors of the Company agreed to satisfy $278,653 of the bonus owed to its executive officers (collectively, the “Management”). Management agreed to accept 278 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. Licensing agreement Pursuant to an agreement dated April 8, 2016, between the Company and Rice University, Rice University has granted a non-exclusive license to the Company, in nanotube-based surface treatment for strengthening glass and related materials under Rice’s intellectual property rights, to use, make, distribute, offer and sell the licensed products specified in the agreement. In consideration for which, the Company had to pay a one-time non-refundable license fee of $10,000 and royalty payments of 5% of net sales of the licensed products during the term of the agreement and a sell-off period of 180 days from termination, In addition, the Company is required to pay for the maintenance of the patents, This agreement will continue until the expiration of the last to expire of the licensed property rights, unless terminated earlier in accordance with the terms of the agreement. There have been no royalty payments paid or due through December 31, 2021. Anti-dilution rights related to C-Bond Systems, LLC Prior to the Merger, C-Bond Systems, LLC entered into certain contracts, described below, which provided certain anti-dilution protection to the counterparties to those contracts. The Company believes that these contracts do not apply to any future issuances of equity by C-Bond Systems, Inc. In 2013, pursuant to a subscription agreement, the Company’s subsidiary. C-Bond Systems, LLC issued 2,425,300 common shares. To the extent that during the term of the agreement C-Bond Systems, LLC issues any “down-round” or subsequent investments based upon an enterprise value of less than $2,000,000 (“Dilutive Transaction”) (other than an issuance pursuant to an option agreement with an employee or otherwise to compensate an employee, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units were issued to the seller of such assets) contemporaneously with the Dilutive Transaction, the contract obligated C-Bond Systems, LLC to issue the investor additional common units in C-Bond Systems, LLC in an amount which would provide them with the ownership percentage interest which they would have held in C-Bond Systems, LLC represented by the common units purchased by them on this date. In 2015, pursuant to a subscription agreement, C-Bond Systems, LLC issued 3,880,480 common shares to an entity at $0.77 per common share. This agreement entitled the subscriber to anti-dilution protection to the extent that C-Bond Systems, LLC issued any equity in a “down-round” based upon a value of less than $0.77 per common unit of C-Bond Systems, LLC (other than an issuance pursuant to an option agreement with an employee or consultant or otherwise to compensate an employee or consultant, or incident to an acquisition of assets by C-Bond Systems, LLC in which common units are issued to the seller of such assets (“Dilutive Transaction”)). Contemporaneously with the Dilutive Transaction the contract obligated C-Bond Systems, LLC to issue the Subscriber additional common units in C-Bond Systems, LLC in an amount which would provide the investor with the ownership percentage interest in C-Bond Systems, LLC on a fully diluted basis which Subscriber held immediately prior to the Dilutive Transaction. In 2016, pursuant to a subscription agreement, C-Bond Systems, LLC issued 1,175,902 common shares to an entity at $0.85 per common share. This agreement entitled this investor to customary broad-based weighted average anti-dilution protection to the extent that after the date of this subscription agreement C-Bond Systems, LLC issued any equity in a “down round” based upon a value of less than $0.85 per common share, including the issuance of options with an exercise price per share of less than $0.85 to compensate employees or consultants (“Dilutive Transaction”), subject to exclusions for issuances of common shares or options in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions. The agreement obligated C-Bond Systems, LLC to give to this investor written notice (an “Issuance Notice”) of any proposed issuance by C-Bond Systems, LLC of any C-Bond Systems, LLC common units, or other form of equity interest (excluding issuances of C-Bond Systems, LLC options or other equity to compensate employees or consultants and the issuance of shares in connection with strategic partnerships, equity kickers to lenders or vendors, mergers or acquisitions) at least ten business days prior to the proposed issuance date. This contract entitled the investor to purchase their pro rata portion of such shares or other equity interest of C-Bond Systems, LLC at the price and on the other terms and conditions specified in the issuance notice.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 12 – INCOME TAXES The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The deferred tax assets on December 31, 2021 and 2020 consist only of net operating loss carryforwards. The net deferred tax asset has been fully offset by a valuation allowance because of the uncertainty of the attainment of future taxable income. The items accounting for the difference between income taxes at the effective statutory rate and the provision for income taxes for the years ended December 31, 2021 and 2020 were as follows: 2021 2020 Income tax benefit at U.S. statutory rate $ (1,497,060 ) $ (931,233 ) Non-deductible expenses 894,825 457,894 Change in valuation allowance 602,235 473,339 Total provision for income tax $ - $ - The Company’s approximate net deferred tax asset as of December 31, 2021 and 2020 was as follows: Deferred Tax Asset: December 31, December 31, Net operating loss carryforward $ 1,938,102 $ 1,335,867 Total deferred tax asset before valuation allowance 1,938,102 1,335,867 Valuation allowance (1,938,102 ) (1,335,867 ) Net deferred tax asset $ - $ - The net operating loss carryforward was approximately $9,229,000 on December 31, 2021. The Company provided a valuation allowance equal to the net deferred income tax asset as of December 31, 2021 and 2020 because it was not known whether future taxable income will be sufficient to utilize the loss carryforward. During the year ended December 31, 2021, the valuation allowance increased by $602,235. Additionally, the future utilization of the net operating loss carryforward to offset future taxable income is subject to an annual limitation as a result of ownership changes that may occur in the future. The potential tax benefit arising from the loss carryforward may be carried forward indefinitely subject to usage limitations. The Company does not have any uncertain tax positions or events leading to uncertainty in a tax position. The Company’s 2021, 2020 and 2019 Corporate Income Tax Returns are subject to Internal Revenue Service examination.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
CONCENTRATIONS	NOTE 13 – CONCENTRATIONS Concentrations Of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade accounts receivable and cash deposits. The Company places its cash in banks at levels that, at times, may exceed federally insured limits. On December 31, 2021, the Company had approximately $132,000 of cash in excess of FDIC limits of $250,000. The Company has not experienced any losses in such accounts through December 31, 2021. Geographic Concentrations of Sales During the year ended December 31, 2021, all sales were in the United States. For the year ended December 31, 2020, approximately 40.1% of all sales were in the United States, 21.5% of sales were from one customer based in India, and 18.6% of sales were from one customer based in the Philippines. No other geographical area accounting for more than 10% of total sales during the year ended December 31, 2020. Customer Concentrations For the year ended December 31, 2021, three customers accounted for approximately 44.2% of total sales (17.4%, 15.3%, and 11.5%, respectively). For the year ended December 31, 2020, two customers accounted for approximately 40.1% of total sales (18.6% and 21.5%, respectively). On December 31, 2021, one customer accounted for 21.4% of the total accounts receivable balance. On December 31, 2020, one customer accounted for 64.0% of the total accounts receivable balance. Vendor concentrations Generally, the Company purchases substantially all of its inventory from five suppliers. The loss of these suppliers may have a material adverse effect on the Company’s consolidated results of operations and financial condition. However, the Company believes that, if necessary, alternate vendors could supply similar products in adequate quantities to avoid material disruptions to operations.

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
SEGMENT REPORTING	NOTE 14 – SEGMENT REPORTING During the year ended December 31, 2020, the Company operated in one reportable business segment, which consisted of the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”). During the year ended December 31, 2021, the Company operated in two reportable business segments - (1) the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system (the “C-Bond Segment”), and (2) the distribution and installation of window film solutions (the “Mobile Tint Segment”). The Company’s reportable segments were strategic business units that offered different products. They were managed separately based on the fundamental differences in their operations and locations. Information with respect to these reportable business segments for the years ended December 31, 2021 and 2020 was as follows: For the Year Ended 2021 2020 (As Restated) Revenues: C-Bond $ 434,811 $ 555,863 Mobile Tint 1,042,017 - 1,476,828 555,863 Depreciation and amortization: C-Bond 9,889 14,093 Mobile Tint 36,078 - 45,967 14,093 Interest expense: C-Bond 1,372 402 Mobile Tint 3,354 - Other (a) 278,233 750,782 282,959 751,184 Net (loss) income: C-Bond (2,001,725 ) (2,393,269 ) Mobile Tint 77,626 - Other (a) (5,204,759 ) (2,041,174 ) $ (7,128,858 ) $ (4,434,443 ) December 31, December 31, Identifiable long-lived tangible assets on December 31, 2021 and 2020 by segment C-Bond $ 8,794 $ 18,683 Mobile Tint 126,228 - $ 135,022 $ 18,683 (a) The Company does not allocate any general and administrative expense of its holding company activities to its reportable segments, because these activities are managed at the corporate level.

Revenue Recognition

Revenue Recognition	12 Months Ended
	Dec. 31, 2021
Revenue Recognition [Abstract]
REVENUE RECOGNITION	NOTE 15 – REVENUE RECOGNITION In connection with the Company’s C-Bond segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s performance obligations under purchase orders or by a verbal order correspond to each shipment of product that the Company makes to its customer under the purchase order or verbal order. As a result, each purchase order or verbal order generally contains more than one performance obligation based on the number of products ordered, the quantity of product to be shipped and the mode of shipment requested by the customer. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs at the later of when the customer obtains title to the product or when the customer assumes risk of loss of the product. The transfer of control generally occurs at a point of shipment from the Company’s warehouse. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue. In connection with the Company’s C-Bond segment, when the Company receives a purchase order or verbal order from a customer, the Company is obligated to provide the product during a mutually agreed upon time period. Depending on the terms of the purchase order or verbal order, either the Company or the customer arranges delivery of the product to the customer’s intended destination. In situations where the Company has agreed to arrange delivery of the product to the customer’s intended destination and control of the product transfers upon loading of the Company’s product onto transportation equipment, the Company has elected to account for any freight income associated with the delivery of these products as freight revenue, since this activity fulfills the Company’s obligation to transfer the product to the customer. In connection with the Company’s Mobile Tint segment, the revenue that the Company recognizes arises from purchase requests the Company receives from its customers. The Company’s performance obligations under purchase order or a signed proposal correspond to each job for the distribution and installation of window film solutions. As a result, each purchase order or signed proposal generally may contain more than one performance obligation based on the specific job. Control of the Company’s products transfers to its customers when the customer is able to direct the use of, and obtain substantially all of the benefits from, the Company’s products, which generally occurs when the job or a specific portion of the job is completed. Once this occurs, the Company has satisfied its performance obligation and the Company recognizes revenue. Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output of input methods including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these methods to be the best available measure of progress on these contracts. Transaction Price The Company agrees with its customers on the selling price of each transaction. This transaction price is generally based on the product, market conditions, including supply and demand balances, labor costs, and freight. In the Company’s C-Bond contracts with customers, the Company allocates the entire transaction price to the sale of product to the customer, which is the basis for the determination of the relative standalone selling price allocated to each performance obligation. Returns of the Company’s product by its customers are permitted only when the product is not to specification and were not material for the years ended December 31, 2021 and 2020. Any sales tax, value added tax, and other tax the Company collects concurrently with its revenue-producing activities are excluded from revenue. Revenue Disaggregation The Company tracks its revenue by product. The following table summarizes our revenue by product for the year ended December 31, 2021 and 2020: For the Year For the Year (As Restated) C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems $ 184,424 $ 155,755 C-Bond Nanoshield solution sales 222,999 118,081 Disinfection products 7,306 250,208 C-Bond installation and other services 12,143 8,992 Window tint installation and sales recognized over time 1,042,017 - Freight and delivery 7,939 22,827 Total $ 1,476,828 $ 555,863

Operating Lease Right-of-Use (_

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities	12 Months Ended
	Dec. 31, 2021
Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities [Abstract]
OPERATING LEASE RIGHT-OF-USE ("ROU") ASSETS AND OPERATING LEASE LIABILITIES	NOTE 16 – OPERATING LEASE RIGHT-OF-USE (“ROU”) ASSETS AND OPERATING LEASE LIABILITIES In October 2019, the Company entered into an 18-month lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021, monthly rent shall be $4,577 per month. On May 12, 2021 and effective June 1, 2021, the Company entered into an amendment to the lease which extended the lease for one year until May 31, 2022 at a monthly base rent of $5,283. In connection with the Exchange Agreement, the Company was named as guarantor (“Guarantor”) of a Commercial Lease Agreement dated July 21, 2021, by and between landlord MDW Management, LLC, a company owned by Michael Wanke and his wife and tenant Mobile Tint, LLC d/b/a A-1 Glass (the “Lease”). The term of the Lease is 60 months, at a minimum monthly rent of $5,600 (not including tax), with two five-year options for the tenant to renew. The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Mobile; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Mobile; or (iii) two (2) years from and after the effective date of the guaranty. In September 2021, the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025. The monthly base rent is $365 per month. In adopting ASC Topic 842, Leases (Topic 842) on January 1, 2019, the Company had elected the ‘package of practical expedients’, which permitted it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs (see Note 2). In addition, the Company elected not to apply ASC Topic 842 to arrangements with lease terms of 12 month or less. Since the terms of the Company’s operating lease for its office space prior to October 2019 was 12 months or less on the date of adoption, pursuant to ASC 842, the Company determined that the lease met the definition of a short-term lease, and the Company did not recognize the right-of use asset and lease liability arising from this lease. Upon renewal of the lease in October 2019, the Company analyzed the new lease and determined it is required to record a lease liability and a right of use asset on its consolidated balance sheet, at fair value. During the years ended December 31, 2021 and 2020, in connection with its operating leases, the Company recorded rent expense of $119,192 and $95,811, respectively, which included rent on a short-term lease for a corporate apartment and is expensed during the period and included in operating expenses on the accompanying consolidated statements of operations. The significant assumption used to determine the present value of the lease liabilities in October 2020 and July 2021 was a discount rate of 12% which was based on the Company’s estimated average incremental borrowing rate. On December 31, 2021 and 2020, right-of-use asset (“ROU”) is summarized as follows: December 31, December 31, Office leases and office equipment right of use assets $ 269,590 $ 74,296 Less: accumulated amortization (18,418 ) (52,524 ) Balance of ROU assets $ 251,172 $ 21,772 On December 31, 2021 and 2020, operating lease liabilities related to the ROU assets are summarized as follows: December 31, 2021 December 31, Lease liabilities related to office leases right of use assets $ 251,246 $ 22,216 Less: current portion of lease liabilities (44,927 ) (22,216 ) Lease liabilities – long-term $ 206,319 $ - On December 31, 2021, future minimum base lease payments due under non-cancelable operating leases are as follows: Year ended December 31, Amount 2022 $ 71,578 2023 71,578 2024 71,578 2025 70,483 2026 39,200 Total minimum non-cancelable operating lease payments 324,417 Less: discount to fair value (73,171 ) Total lease liability on December 31, 2021 $ 251,246

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 17 – RELATED PARTY TRANSACTIONS Due From Related Party On December 31, 2021 and 2020, the Company has an amount due from the Company’s chief executive officer of $0 and $5,526 related to the overpayment of accrued compensation, respectively. In December 2021, the Company advanced $3,750 to a company partially owned by officers of the Company. The advance is non-interest bearing, payable on demand, and is reflected as due from related party on the accompanying consolidated balance sheet. Sales and Accounts Receivable – Related Party During the year ended December 31, 2021, the Company recognized sales of $1,200 to a company partially owned by officers of the Company.

Restatement

Restatement	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
RESTATEMENT	NOTE 18 - RESTATEMENT On April 11, 2022, the Company’s management determined that the Company’s consolidated financial statements for the year ended December 31, 2020 included herein should be restated because management determined that it had overstated its sales and bad debt expense in its consolidated financial statements for the year ended December 31, 2020. Based on management’s analysis, the Company determined that a sale in the amount of $102,569 that was recorded in December 2020 did not meet the Company’s revenue recognition policy pursuant to ASC 606 and should not have been reflected as a sale. Additionally, in the same period, in connection with the Company’s analysis of collectability, the Company recorded a bad debt allowance and a related bad debt expense of $102,569. Since the sale and related allowance for bad debt should not have been recorded, the Company is restating its consolidated financial statements to reduce sales and bad debt expense by $102,569. Accordingly, the Company’s consolidated statement of operations and cash flows for the year ended December 31, 2020 have been restated herein. The effect of correcting this error in the Company’s consolidated financial statements on December 31, 2020 and for the year ended December 31, 2020 are summarized and shown in the table as follows: Consolidated Statement of Operations: As Previously Adjustments As Restated Sales $ 658,432 $ (102,569 ) $ 555,863 Operating Expenses: General and administrative expenses – bad debt expense 588,302 (102,569 ) 485,733 Total Operating Expenses 4,892,959 (102,569 ) 4,790,390 Loss from Operations $ (4,477,033 ) $ - $ (4,477,033 ) Consolidated Statement of Cash Flows: Net loss $ (4,434,443 ) $ - $ (4,434,443 ) Adjustments to reconcile net loss to net cash used in operating activities: Bad debt expense 202,480 (102,569 ) 99,911 Change in operating assets and liabilities: Accounts receivable (130,188 ) 102,569 (27,619 ) NET CASH USED IN OPERATING ACTIVITIES $ (1,783,027 ) $ - $ (1,783,027 )

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 19 – SUBSEQUENT EVENTS Issuance of Series B preferred stock for accrued compensation On January 6, 2022, the Board of Directors of the Company agreed to satisfy $278,653 of accrued compensation owed to its executive officers (collectively, the “Management”) as of December 31, 2021 and included in accrued compensation on the accompanying consolidated balance sheet. Management agreed to accept 278 shares of the Company’s Series B convertible preferred stock in settlement of this accrued compensation. Common Stock Issued for Conversion of Series C Preferred Stock On January 12, 2022, the Company issued 1,543,151 shares its common stock upon the conversion of 120 shares of Series C preferred with a stated redemption value of $12,000. The conversion price was based on contractual terms of the related Series C preferred shares. Common stock issued for Accounts Payable On January 6, 2022, the Company issued 90,859 common shares upon conversion of accounts payable of $2,180, or $0.024 per common share, based on contemporaneous common share sales by the Company. Common stock issued for Services Rendered On March 24, 2022, the Company granted restricted stock awards of 500,000 common shares of the Company to an employee of the Company for services rendered. which were valued at $14,250, or $0.0285 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. Promissory note On March 14, 2022, the Company entered into an Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500 with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the Company received net proceeds of $175,000 which is net of an Original Issue Discount of $22,500, which included $5,000 of the Investor’s legal fees. The March 2022 Note matures 12 months after issuance and bears interest at a rate of 3% per annum. At any time, the Company may prepay all or any portion of the principal amount of the March 2022 Note and any accrued and unpaid interest without penalty. The March 2022 Note also creates a lien on and grants a priority security interest in all of the Company’s assets. Common Stock Issued in Connection with March 2022 Note In connection with the March 2022 Note, the Company issued 823,529 shares of its common stock to the placement agent as fee for the capital raise. The 823,529 shares of common stock issued were recorded as a debt discount of $12,963 based on the relative fair value method to be amortized over the life of the Note. SEC Order On January 20, 2022, we received an Order Directing Examination and Designating Officers to Take Testimony (a “Formal Order”) from the SEC. The Formal Order authorizes that an examination be made to determine whether a stop order should be issued under Section 8(d) of the Securities Act of 1933 with respect to the Company’s Registration Statement on Form S-1, and any supplements and amendments thereto. The Formal Order indicates that the Form S-1 may be deficient in that it may contain untrue statements of material fact or omit to state material facts necessary in order to make the statements made, in light of the circumstances under which they were made, not misleading concerning, among other things, the Company’s revenue and financial condition.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The Company’s consolidated financial statements include the financial statements of its wholly owned subsidiary, C-Bond Systems, LLC and its 80% owned subsidiary, Mobile Tint LLC since acquiring 80% of Mobile Tint LLC on July 22, 2021. All significant intercompany accounts and transactions have been eliminated in consolidation.
Going Concern	Going Concern These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying consolidated financial statements, the Company had a net loss of $7,128,858 and $4,434,443 for the years ended December 31, 2021 and 2020, respectively. The net cash used in operations was $1,807,051 and $1,783,027 for the years ended December 31, 2021 and 2020, respectively. Additionally, the Company had an accumulated deficit, shareholders’ deficit, and working capital deficit of $57,515,129, $3,979,041 and $1,661,247, respectively, on December 31, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of twelve months from the issuance date of this report. Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive or raise additional debt and/or equity capital. The Company is seeking to raise capital through additional debt and/or equity financings to fund its operations in the future. Although the Company has historically raised capital from sales of common shares and preferred shares, and from the issuance of promissory notes and convertible promissory notes, there is no assurance that it will be able to continue to do so. If the Company is unable to raise additional capital or secure additional lending in the near future, management expects that the Company will need to curtail its operations. These consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates during the years ended December 31, 2021 and 2020 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, purchase price allocation of acquired businesses, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the fair value of derivative liabilities, the value of beneficial conversion features, and the fair value of non-cash equity transactions.
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements The Company analyzes all financial instruments with features of both liabilities and equity under the Financial Accounting Standard Board’s (the “FASB”) accounting standard for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Disclosures about the fair value of financial instruments are based on pertinent information available to the Company on December 31, 2021 and 2020. Accordingly, the estimates presented in these consolidated financial statements are not necessarily indicative of the amounts that could be realized on disposition of the financial instruments. FASB Accounting Standards Codification (“ASC”) 820 specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement). The three levels of the fair value hierarchy are as follows: Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2—Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3—Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The carrying amounts reported in the consolidated balance sheets for cash, accounts receivable, notes payable – related party, convertible note payable, accounts payable, accrued expenses, accrued compensation, and lease liability approximate their fair market value based on the short-term maturity of these instruments. Assets and liabilities measured at fair value on a recurring basis on December 31, 2021 and 2020 is as follows: On December 31, 2021 On December 31, 2020 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ - $ - $ - $ - $ - $ - A roll forward of the level 3 valuation financial instruments is as follows: For the Year Ended 2021 2020 Balance at beginning of period $ - $ 890,410 Initial valuation of derivative liabilities included in debt discount - 85,502 Initial valuation of derivative liabilities included in derivative expense - 160,416 Gain on extinguishment of debt related to repayment/conversion of debt - (1,066,535 ) Change in fair value included in derivative expense - (69,793 ) Balance at end of period $ - $ - ASC 825-10 “Financial Instruments”, allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable, unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. The Company did not elect to apply the fair value option to any outstanding instruments.
Cash and Cash Equivalents	Cash And Cash Equivalents For purposes of the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents. The Company has no cash equivalents as of December 31, 2021 and 2020.
Accounts Receivable	Accounts Receivable The Company recognizes an allowance for losses on accounts receivable in an amount equal to the estimated probable losses net of recoveries. The allowance is based on an analysis of historical bad debt experience, current receivables aging, and expected future write-offs, as well as an assessment of specific identifiable customer accounts considered at risk or uncollectible. The expense associated with the allowance for doubtful accounts is recognized as general and administrative expense.
Inventory	Inventory Inventory, consisting of raw materials and finished goods, are stated at the lower of cost and net realizable value utilizing the first-in, first-out (FIFO) method. A reserve is established when management determines that certain inventories may not be saleable. If inventory costs exceed expected net realizable value due to obsolescence or quantities in excess of expected demand, the Company will record reserves for the difference between the cost and the net realizable value. These reserves are recorded based on estimates and included in cost of sales.
Property and Equipment	Property And Equipment Property and equipment are stated at cost and are depreciated using the straight-line method over their estimated useful lives, which range from one to five years. Leasehold improvements are depreciated over the shorter of the useful life or lease term including scheduled renewal terms. Maintenance and repairs are charged to expense as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition. The Company examines the possibility of decreases in the value of these assets when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Any goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets may have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets are being amortized over a useful life of 5 years.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets In accordance with ASC Topic 360, the Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value.
Derivative Financial Instruments	Derivative Financial Instruments The Company had certain financial instruments that were embedded derivatives. The Company evaluated all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4, Derivatives and Hedging Contracts in Entity’s Own Equity In July 2017, FASB issued Accounting Standards Update (“ASU”) No. 2017-11, Earnings Per Share Distinguishing Liabilities from Equity Derivatives and Hedging Accounting for Certain Financial Instruments with Down Round Features
Revenue Recognition	Revenue Recognition The Company follows ASC Topic 606, Revenue from Contracts with Customers The Company sells its products which include standard warranties primarily to distributors and authorized dealers. Product sales are recognized at a point in time when the product is shipped to the customer and title is transferred and are recorded net of any discounts or allowances. The warranty does not represent a separate performance obligation. Revenues from contracts for the distribution and installation of window film solutions are recognized over time on the basis of the Company’s estimates of the progress towards completion of contracts using various output or input methods depending on the type of contract terms including (1) the ratio of number of labor hours spent compared to the number of estimated labor hours to complete a job, (2) using the milestone method, or (3) using a units completed method. These methods are used because management considers these to be the best available measure of progress on these contracts. We use the same method for similar types of contracts. The asset, “contract assets” represents revenues recognized in excess of amounts billed. The liability, “contract liabilities,” represents billings in excess of revenues recognized.
Cost of Sales	Cost of Sales Cost of sales includes inventory costs, packaging costs and warranty expenses. Cost of revenues from fixed-price contracts for the distribution and installation of window film solutions include all direct material, sub-contractor, labor and certain other direct costs, as well as those indirect costs related to contract performance, such as indirect labor and fringe benefits. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions and estimated profitability may result in revisions to cost and income, which are recognized in the period in which the revisions are determined. Changes in estimated job profitability resulting from job performance, job conditions, claims, change orders, and settlements, are accounted for as changes in estimates in the current period.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs incurred for product shipped to customers are included in general and administrative expenses and amounted to $15,431 and $49,515 for the year ended December 31, 2021 and 2020, respectively. Shipping and handling costs charged to customers are included in sales.
Research and Development	Research and Development Research and development costs incurred in the development of the Company’s products are expensed as incurred and includes costs such as labor, materials, and other allocated costs incurred. For the year ended December 31, 2021 and 2020, research and development costs (recovery) incurred in the development of the Company’s products were $(3,250) and $16,627, respectively, and are included in operating expenses on the accompanying consolidated statements of operations. In April 2021, the Company received a refund of research and development costs of $3,250.
Warranty Liability	Warranty Liability The Company provides limited warranties on its products for product defects for periods ranging from 12 months to the life of the product. Warranty costs may include the cost of product replacement, refunds, labor costs and other costs. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product warranty claim rates and expected costs to repair or to replace the products under warranty. The Company currently establishes warranty reserves based on historical warranty costs for each product line combined with liability estimates based on the prior 12 months’ sales activities. If actual return rates and/or repair and replacement costs differ significantly from the Company’s estimates, adjustments to recognize additional cost of sales may be required in future periods. Historically the warranty accrual and the expense amounts have been immaterial. The warranty liability is included in accrued expenses on the accompanying consolidated balance sheets and amounted $26,733 and $26,833 on December 31, 2021 and 2020, respectively. For the years ended December 31, 2021 and 2020, warranty costs amounted to $100 for both periods which has been deducted from warranty liability. For the years ended December 31, 2021 and 2020, a roll forward of warranty liability is as follows: For the Year Ended 2021 2020 Balance at beginning of period $ 26,833 $ 26,933 Warranty costs incurred (100 ) (100 ) Balance at end of period $ 26,733 $ 26,833
Advertising Costs	Advertising Costs The Company may participate in various advertising programs. All costs related to advertising of the Company’s products are expensed in the period incurred. For the year ended December 31, 2021 and 2020, advertising costs charged to operations were $65,626 and $46,276, respectively and are included in general and administrative expenses on the accompanying consolidated statements of operations. These advertising expenses do not include cooperative advertising and sales incentives which shall been deducted from sales.
Federal and State Income Taxes	Federal and State Income Taxes The Company accounts for income tax using the liability method prescribed by ASC 740, “Income Taxes”. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date. The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740 “Income Taxes
Stock-Based Compensation	Stock-Based Compensation Stock-based compensation is accounted for based on the requirements of ASC 718 – “Compensation –Stock Compensation Improvements to Employee Share-Based Payment
Loss Per Common Share	Loss Per Common Share ASC 260 “Earnings Per Share”, requires dual presentation of basic and diluted earnings per common share (“EPS”) with a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. Basic EPS excludes dilutive securities and non-vested forfeitable shares. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares or resulted in the issuance of common shares that then shared in the earnings of the entity. Basic net loss per common share is computed by dividing net loss available to members by the weighted average number of common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of common shares, common share equivalents and potentially dilutive securities outstanding during each period. Potentially dilutive common shares consist of stock options and non-vested forfeitable shares (using the treasury stock method) and shares issuable upon conversion of preferred shares and convertible notes payable (using the as-if converted method). These common share equivalents may be dilutive in the future. All potentially dilutive common shares were excluded from the computation of diluted common shares outstanding as they would have an anti-dilutive impact on the Company’s net losses and consisted of the following: December 31, 2021 2020 Stock options 8,445,698 8,445,698 Warrants 17,500,000 2,050,000 Series B preferred stock 114,598,413 68,166,032 Series C preferred stock 296,507,937 211,111,111 Convertible debt 33,000,000 - Non-vested, forfeitable common shares 14,270,120 23,826,926 484,322,168 313,599,767
Segment Reporting	Segment Reporting During the year ended December 31, 2020, the Company operated in one reportable business segment, which consisted of the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system. During the year ended December 31, 2021, the Company operated in two reportable business segments which consisted of (1) the manufacture and sale of a windshield strengthening water repellent solution as well as a disinfection product, and the sale of multi-purpose glass strengthening primer and window film mounting solutions, including ballistic-resistant film systems and a forced entry system, and (2) the distribution and installation of window film solutions. The Company’s reportable segments were strategic business units that offered different products. They were managed separately based on the fundamental differences in their operations and locations.
Leases	Leases In February 2016, the FASB issued ASU 2016-02, “ Leases (Topic 842)” Operating lease ROU assets represents the right to use the leased asset for the lease term and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As most leases do not provide an implicit rate, the Company use an incremental borrowing rate based on the information available at the adoption date in determining the present value of future payments. Lease expense for minimum lease payments is amortized on a straight-line basis over the lease term and is included in general and administrative expenses in the consolidated statements of operations.
Noncontrolling Interest	Noncontrolling Interest The Company accounts for noncontrolling interest in accordance with ASC Topic 810-10-45, which requires the Company to present noncontrolling interests as a separate component of total shareholders’ equity on the consolidated balance sheets and the consolidated net loss attributable to its noncontrolling interest be clearly identified and presented on the face of the consolidated statements of operations.
Risk and Uncertainties	Risk and Uncertainties In March 2020, the World Health Organization declared COVID-19 a global pandemic and recommended containment and mitigation measures worldwide. The Company is monitoring this closely. The Company has been materially affected by the COVID-19 outbreak to date and the ultimate duration and severity of the outbreak and its impact on the economic environment and our business is uncertain. The Company has seen a material decrease in sales from its international customers as a result of the unprecedented public health crisis from the COVID-19 pandemic and a decrease in domestic sales due to a decrease in business spending on discretionary items. As a result, the Company’s international customers have delayed the ordering of products and have delayed payment of balances due to the Company. As of December 31, 2021 and 2020, the Company recognized an allowance for losses on accounts receivable in an amount of $31,556 and $202,480, respectively. As of December 31, 2020, the allowance for losses on accounts receivable was primarily based on the Company’s assessment of specific identifiable overdue customer accounts located in India and the Philippines. The lack of collection of these accounts receivable balances, which the Company believes was attributable to COVID-19, had a material impact on the cash flows of the Company. The Company cannot estimate the duration of the pandemic and the future impact on its business. A severe or prolonged economic downturn could result in a variety of risks to the Company’s business, including weakened demand for its products and a decreased ability to raise additional capital when needed on acceptable terms, if at all. Currently, the Company is unable to estimate the impact of this event on its operations.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In December 2019, the FASB issued ASU No. 2019-12 – Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments in ASU 2020-12 eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 also clarifies and simplifies other aspects of the accounting for income taxes. The amendments in ASU 2019-12 will become effective for us as of the beginning of our 2022 fiscal year. Early adoption is permitted, including adoption in any interim period. We are currently evaluating the impact that this guidance will have upon our financial position and results of operations, if any. In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The ASU simplifies accounting for convertible instruments by removing major separation models required under current GAAP. Consequently, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. The ASU also simplifies the diluted net income per share calculation in certain areas. The new guidance is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and early adoption is permitted. The Company is currently evaluating the impact of the adoption of the standard on the consolidated financial statements. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Schedule of assets and liabilities measured at fair value	On December 31, 2021 On December 31, 2020 Description Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Derivative liabilities $ - $ - $ - $ - $ - $ -
Schedule of roll forward of the level 3 valuation financial instruments	For the Year Ended 2021 2020 Balance at beginning of period $ - $ 890,410 Initial valuation of derivative liabilities included in debt discount - 85,502 Initial valuation of derivative liabilities included in derivative expense - 160,416 Gain on extinguishment of debt related to repayment/conversion of debt - (1,066,535 ) Change in fair value included in derivative expense - (69,793 ) Balance at end of period $ - $ -
Schedule of warranty liability	For the Year Ended 2021 2020 Balance at beginning of period $ 26,833 $ 26,933 Warranty costs incurred (100 ) (100 ) Balance at end of period $ 26,733 $ 26,833
Schedule of diluted common shares outstanding	December 31, 2021 2020 Stock options 8,445,698 8,445,698 Warrants 17,500,000 2,050,000 Series B preferred stock 114,598,413 68,166,032 Series C preferred stock 296,507,937 211,111,111 Convertible debt 33,000,000 - Non-vested, forfeitable common shares 14,270,120 23,826,926 484,322,168 313,599,767

Acquisition of Mobile Tint LLC

Acquisition of Mobile Tint LLC (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combinations [Abstract]
Schedule of fair value of the assets acquired and liabilities assumed	Total Assets acquired: Cash $ 288,901 Accounts receivable, net 59,726 Inventory 68,019 Prepaid expenses and other 6,091 Contract assets 32,699 Property and equipment 140,211 Right of use asset 253,433 Intangible assets 352,516 Goodwill 350,491 Total assets acquired at fair value 1,552,087 Less: total liabilities assumed: Notes payable 95,013 Accounts payable 65,728 Accrued expenses 159,262 Customer deposit 110,000 Lease liability 253,433 Noncontrolling interest 173,730 Total liabilities assumed 857,166 Net assets acquired $ 694,921 Purchase consideration paid: Fair value of common shares issued $ 694,921 Total purchase consideration paid $ 694,921
Schedule of unaudited pro forma consolidated results of operations	For the Year Ended For the Year Ended Net Revenues $ 2,168,863 $ 2,635,627 Net Loss $ (7,128,027 ) $ (4,159,008 ) Net Loss per Share $ (0.03 ) $ (0.02 )

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Schedule of accounts receivable	December 31, December 31, (As Restated) Accounts receivable $ 204,804 $ 179,608 Less: allowance for doubtful accounts (31,556 ) (99,911 ) Accounts receivable, net $ 173,248 $ 79,697 (a) (a) See Note 18 – Restatement for details.

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of inventory consisted	December 31, December 31, Raw materials $ 7,141 $ 24,477 Finished goods 120,790 52,723 Inventory 127,931 77,200 Less: allowance for obsolete or slow moving inventory (45,000 ) - Inventory, net $ 82,931 $ 77,200

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Useful Life December 31, December 31, Machinery and equipment 5 - 7 years $ 124,133 $ 50,722 Furniture and office equipment 3 - 7 years 32,306 30,245 Vehicles 1 - 5 years 63,009 55,941 Leasehold improvements 3 - 5 years 45,296 16,701 264,744 153,609 Less: accumulated depreciation (129,722 ) (134,926 ) Property and equipment, net $ 135,022 $ 18,683

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible asset	Useful life December 31, December 31, Customer relations 5 years $ 212,516 $ - Non-compete 5 years 40,000 - Trade name - 100,000 - 352,516 - Less: accumulated amortization (22,095 ) - Intangible assets, net $ 330,421 $ - Useful life December 31, December 31, Goodwill - $ 350,491 $ -
Schedule of amortization of intangible assets	Year ending December 31: Amount 2022 $ 50,503 2023 50,503 2024 50,503 2025 50,503 2026 28,409 Total $ 230,421

Convertible Note Payable (Table

Convertible Note Payable (Tables)	12 Months Ended
	Dec. 31, 2021
Convertible Note Payable [Abstract]
Schedule of fair value of the derivative liabilities and warrants was estimated using the binomial valuation model	2020 Dividend rate — Term (in years) 0.25 to 5.00 years Volatility 293.4% to 345.7 % Risk—free interest rate 0.12% to 0.39 %
Schedule of fair value of the stock warrants was estimated at issuance using the binomial valuation model	Dividend rate — % Term (in years) 5 years Volatility 348.5 % Risk—free interest rate 1.16 %
Schedule of convertible notes payable	December 31, December 31, Convertible note payable $ 825,000 $ - Less: unamortized debt discount (653,125 ) - Convertible note payable, net 171,875 - Less: current portion of convertible note payable (171,875 ) - Convertible note payable – long-term $ - $ -

Notes Payable (Tables)

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2021
Notes Payable Disclosure [Abstract]
Schedule of notes payable	December 31, December 31, Notes payable $ 978,925 $ 400,000 Note payable – PPP note 48,929 156,200 Total notes payable 1,027,854 556,200 Less: current portion of notes payable (488,414 ) (521,138 ) Notes payable – long-term $ 539,440 $ 35,062
Schedule of future annual maturities of notes payable	December 31, Amount 2022 $ 488,414 2023 530,720 2024 6,458 2025 2,262 Total notes payable on December 31, 2021 $ 1,027,854

Shareholders' Deficit (Tables)

Shareholders' Deficit (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity Note [Abstract]
Schedule of redemption period	Redemption Period Redemption 1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date. 100% 2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date. 107% 3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date. 112% 4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date. 117% 5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date. 120%
Schedule of activity related to non-vested shares	Number of Weighted Non-vested, December 31, 2019 17,675,299 $ 0.23 Granted 7,450,000 0.04 Shares vested (1,298,373 ) (0.41 ) Non-vested, December 31, 2020 23,826,926 0.16 Granted 6,194,767 0.06 Forfeited (700,000 ) (0.07 ) Shares vested (15,051,573 ) (0.14 ) Non-vested, December 31, 2021 14,270,120 $ 0.14
Schedule of stock option activities	Number of Weighted Weighted Aggregate Balance Outstanding, December 31, 2019 8,445,698 $ 0.40 Exercised - - Balance Outstanding, December 31, 2020 8,445,698 0.40 5.10 $ 48,000 Exercised - - - - Balance Outstanding, December 31, 2021 8,445,698 $ 0.40 4.10 $ 0 Exercisable, December 31, 2021 8,445,698 $ 0.40 4.10 $ 0
Schedule of warrant activities	Number of Weighted Weighted Aggregate Balance Outstanding December 31, 2019 2,050,000 $ 0.10 Exercised 288,750 0.10 Cancelled (288,750 ) (0.10 ) Balance Outstanding December 31, 2020 2,050,000 0.05 3.66 $ 137,000 Granted 16,500,000 0.05 - - Exercised (1,050,000 ) (0.01 ) - - Balance Outstanding December 31, 2021 17,500,000 $ 0.05 4.67 $ - Exercisable, December 31, 2021 17,500,000 $ 0.05 4.67 $ -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of income taxes at the effective statutory rate	2021 2020 Income tax benefit at U.S. statutory rate $ (1,497,060 ) $ (931,233 ) Non-deductible expenses 894,825 457,894 Change in valuation allowance 602,235 473,339 Total provision for income tax $ - $ -
Schedule of company’s approximate net deferred tax asset	Deferred Tax Asset: December 31, December 31, Net operating loss carryforward $ 1,938,102 $ 1,335,867 Total deferred tax asset before valuation allowance 1,938,102 1,335,867 Valuation allowance (1,938,102 ) (1,335,867 ) Net deferred tax asset $ - $ -

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Schedule of reportable business segments	For the Year Ended 2021 2020 (As Restated) Revenues: C-Bond $ 434,811 $ 555,863 Mobile Tint 1,042,017 - 1,476,828 555,863 Depreciation and amortization: C-Bond 9,889 14,093 Mobile Tint 36,078 - 45,967 14,093 Interest expense: C-Bond 1,372 402 Mobile Tint 3,354 - Other (a) 278,233 750,782 282,959 751,184 Net (loss) income: C-Bond (2,001,725 ) (2,393,269 ) Mobile Tint 77,626 - Other (a) (5,204,759 ) (2,041,174 ) $ (7,128,858 ) $ (4,434,443 )
Schedule of identifiable long-lived tangible assets	December 31, December 31, Identifiable long-lived tangible assets on December 31, 2021 and 2020 by segment C-Bond $ 8,794 $ 18,683 Mobile Tint 126,228 - $ 135,022 $ 18,683

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue Recognition [Abstract]
Schedule of revenue by product	For the Year For the Year (As Restated) C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems $ 184,424 $ 155,755 C-Bond Nanoshield solution sales 222,999 118,081 Disinfection products 7,306 250,208 C-Bond installation and other services 12,143 8,992 Window tint installation and sales recognized over time 1,042,017 - Freight and delivery 7,939 22,827 Total $ 1,476,828 $ 555,863

Operating Lease Right-of-Use _2

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities [Abstract]
Schedule of right-of-use asset	December 31, December 31, Office leases and office equipment right of use assets $ 269,590 $ 74,296 Less: accumulated amortization (18,418 ) (52,524 ) Balance of ROU assets $ 251,172 $ 21,772
Schedule of operating lease liabilities related to the ROU assets	December 31, 2021 December 31, Lease liabilities related to office leases right of use assets $ 251,246 $ 22,216 Less: current portion of lease liabilities (44,927 ) (22,216 ) Lease liabilities – long-term $ 206,319 $ -
Schedule of future minimum base lease payments due under non-cancelable operating leases	Year ended December 31, Amount 2022 $ 71,578 2023 71,578 2024 71,578 2025 70,483 2026 39,200 Total minimum non-cancelable operating lease payments 324,417 Less: discount to fair value (73,171 ) Total lease liability on December 31, 2021 $ 251,246

Restatement (Tables)

Restatement (Tables)	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Schedule of consolidated statement of operations	As Previously Adjustments As Restated Sales $ 658,432 $ (102,569 ) $ 555,863 Operating Expenses: General and administrative expenses – bad debt expense 588,302 (102,569 ) 485,733 Total Operating Expenses 4,892,959 (102,569 ) 4,790,390 Loss from Operations $ (4,477,033 ) $ - $ (4,477,033 ) Consolidated Statement of Cash Flows: Net loss $ (4,434,443 ) $ - $ (4,434,443 ) Adjustments to reconcile net loss to net cash used in operating activities: Bad debt expense 202,480 (102,569 ) 99,911 Change in operating assets and liabilities: Accounts receivable (130,188 ) 102,569 (27,619 ) NET CASH USED IN OPERATING ACTIVITIES $ (1,783,027 ) $ - $ (1,783,027 )

Nature of Organization (Details

Nature of Organization (Details) - USD ($)	1 Months Ended
	Jul. 22, 2021	Jun. 30, 2021
Nature of Organization [Abstract]
Controlling interest, percentage	80.00%	80.00%
Issued and outstanding capital stock		80.00%
Restricted shares (in Shares)	28,021,016
Dividend average (in Dollars)	$ 800,000
Issued and outstanding interest	20.00%
Common stock percent	300.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Apr. 30, 2021	Jul. 22, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Summary of Significant Accounting Policies (Details) [Line Items]
Consolidated financial statements percentage		80.00%
Net loss			$ (7,128,858)	$ (4,434,443)
Cash			132,000
Accumulated deficit			(57,515,129)	(45,968,839)
Shareholders’ Deficit			(3,979,041)	(3,167,220)	$ (2,616,937)
Additional paid-in capital			53,064,616	42,573,272
General and administrative expenses			15,431	49,515
Research and development costs			(3,250)	16,627
Research of development refund	$ 3,250
Warranty liability			26,733	26,833
Warranty costs			100
Advertising costs			65,626	46,276
Allowance for losses on accounts receivable			$ 31,556	202,480
Minimum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful live life			1 year
Maximum [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Estimated useful live life			5 years
C-Bond Systems, LLC [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Consolidated financial statements percentage		80.00%
Goodwill and Intangible Assets [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Useful life			5 years
Going Concern [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Net loss			$ 7,128,858	4,434,443
Cash			$ 1,807,051	1,783,027
Accumulated deficit				57,515,129
Shareholders’ Deficit				3,979,041
Additional paid-in capital				$ 1,661,247

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - Schedule of assets and liabilities measured at fair value - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Level 1 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets and liabilities measured at fair value [Line Items]
Derivative liabilities
Level 2 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets and liabilities measured at fair value [Line Items]
Derivative liabilities
Level 3 [Member]
Summary of Significant Accounting Policies (Details) - Schedule of assets and liabilities measured at fair value [Line Items]
Derivative liabilities

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details) - Schedule of roll forward of the level 3 valuation financial instruments - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of roll forward of the level 3 valuation financial instruments [Abstract]
Balance at beginning of period		$ 890,410
Initial valuation of derivative liabilities included in debt discount		85,502
Initial valuation of derivative liabilities included in derivative expense		160,416
Gain on extinguishment of debt related to repayment/conversion of debt		(1,066,535)
Change in fair value included in derivative expense		(69,793)
Balance at end of period

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details) - Schedule of warranty liability - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of warranty liability [Abstract]
Balance at beginning of period	$ 26,833	$ 26,933
Warranty costs incurred	(100)	(100)
Balance at end of period	$ 26,733	$ 26,833

Summary of Significant Accoun_7

Summary of Significant Accounting Policies (Details) - Schedule of diluted common shares outstanding - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	484,322,168	313,599,767
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	17,500,000	2,050,000
Stock options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	8,445,698	8,445,698
Non-vested, forfeitable common shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	14,270,120	23,826,926
Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	114,598,413	68,166,032
Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	296,507,937	211,111,111
Convertible debt [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share	33,000,000

Acquisition of Mobile Tint LL_2

Acquisition of Mobile Tint LLC (Details) - USD ($)

1 Months Ended

12 Months Ended

Sep. 30, 2021

Jul. 22, 2021

Jun. 30, 2021

Dec. 31, 2021

Jun. 30, 2023

Oct. 18, 2021

Oct. 01, 2021

Dec. 31, 2020

Oct. 09, 2020

Oct. 07, 2020

Oct. 06, 2020

Oct. 01, 2020

Apr. 01, 2020

Mar. 31, 2020

Jan. 13, 2020

Acquisition of Mobile Tint LLC (Details) [Line Items]

Exchange agreement percentage

80.00%

Common stock amount (in Dollars)

$ 800,000

Shares issued (in Shares)

668,151

6,000,000

Value of shares issued (in Dollars)

$ 694,921

Price per common share (in Dollars per share)

$ 0.0248

$ 0.0346

$ 0.054

$ 0.012

$ 0.0085

$ 0.008

$ 0.011

$ 0.04

$ 0.04

$ 0.04

Average value percentage

300.00%

Monthly rent (in Dollars)

$ 365

$ 5,600

Exchange agreement, description

The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Mobile; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Mobile; or (iii) two (2) years from and after the effective date of the guaranty.

Forecast [Member]

Acquisition of Mobile Tint LLC (Details) [Line Items]

Base salary percentage

50.00%

Exchange Agreement [Member]

Acquisition of Mobile Tint LLC (Details) [Line Items]

Shares issued (in Shares)

28,021,016

Business Combination [Member]

Acquisition of Mobile Tint LLC (Details) [Line Items]

Acquire of remaining shares percentage

20.00%

Business Combination [Member] | Mobile’s Member Units [Member]

Acquisition of Mobile Tint LLC (Details) [Line Items]

Acquire percentage

80.00%

Issued and outstanding percentage

80.00%

Acquisition of Mobile Tint LL_3

Acquisition of Mobile Tint LLC (Details) - Schedule of fair value of the assets acquired and liabilities assumed	12 Months Ended
	Dec. 31, 2021USD ($)
Assets acquired:
Cash	$ 288,901
Accounts receivable, net	59,726
Inventory	68,019
Prepaid expenses and other	6,091
Contract assets	32,699
Property and equipment	140,211
Right of use asset	253,433
Intangible assets	352,516
Goodwill	350,491
Total assets acquired at fair value	1,552,087
Less: total liabilities assumed:
Notes payable	95,013
Accounts payable	65,728
Accrued expenses	159,262
Customer deposit	110,000
Lease liability	253,433
Noncontrolling interest	173,730
Total liabilities assumed	857,166
Net assets acquired	694,921
Purchase consideration paid:
Fair value of common shares issued	694,921
Total purchase consideration paid	$ 694,921

Acquisition of Mobile Tint LL_4

Acquisition of Mobile Tint LLC (Details) - Schedule of unaudited pro forma consolidated results of operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of unaudited pro forma consolidated results of operations [Abstract]
Net Revenues	$ 2,168,863	$ 2,635,627
Net Loss	$ (7,128,027)	$ (4,159,008)
Net Loss per Share (in Dollars per share)	$ (0.03)	$ (0.02)

Accounts Receivable (Details)

Accounts Receivable (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Bad debt expense	$ 39,355	$ 99,911

Accounts Receivable (Details) -

Accounts Receivable (Details) - Schedule of accounts receivable - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of accounts receivable [Abstract]
Accounts receivable	$ 204,804	$ 179,608
Less: allowance for doubtful accounts	(31,556)	(99,911)
Accounts receivable, net	$ 173,248	$ 79,697

Inventory (Details)

Inventory (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Inventory allowance	$ 45,000	$ 0

Inventory (Details) - Schedule

Inventory (Details) - Schedule of inventory consisted - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of inventory consisted [Abstract]
Raw materials	$ 7,141	$ 24,477
Finished goods	120,790	52,723
Inventory	127,931	77,200
Less: allowance for obsolete or slow moving inventory	(45,000)
Inventory, net	$ 82,931	$ 77,200

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Proceeds from sale of vehicle	$ 13,000
Gain on sale of asset	13,000
Depreciation and amortization expense	$ 23,872	$ 14,093

Property and Equipment (Detai_2

Property and Equipment (Details) - Schedule of property and equipment - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 264,744	$ 153,609
Less: accumulated depreciation	(129,722)	(134,926)
Property and equipment, net	135,022	18,683
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 124,133	50,722
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Furniture and office equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 32,306	30,245
Furniture and office equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Furniture and office equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	7 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 63,009	55,941
Vehicles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	1 year
Vehicles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 45,296	$ 16,701
Leasehold improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Leasehold improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	5 years

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Intangible Assets and Goodwill (Details) [Line Items]
Amortization of intangible assets	$ 22,095	$ 0
Customer Relations [Member]
Intangible Assets and Goodwill (Details) [Line Items]
Accumulated amortization	18,595
Non-Compete [Member]
Intangible Assets and Goodwill (Details) [Line Items]
Accumulated amortization	$ 3,500

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill (Details) - Schedule of intangible asset - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of intangible asset [Abstract]
Customer relations, useful life	5 years
Customer relations	$ 212,516
Non-compete, useful life	5 years
Non-compete	$ 40,000
Trade name	100,000
Total	352,516
Less: accumulated amortization	(22,095)
Intangible assets, net	330,421
Goodwill	$ 350,491

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill (Details) - Schedule of amortization of intangible assets	Dec. 31, 2021USD ($)
Schedule of amortization of intangible assets [Abstract]
2022	$ 50,503
2023	50,503
2024	50,503
2025	50,503
2026	28,409
Total	$ 230,421

Convertible Note Payable (Detai

Convertible Note Payable (Details) - USD ($)	Oct. 15, 2021	Jan. 07, 2021	Dec. 09, 2019	Sep. 06, 2019	Oct. 18, 2021	Apr. 30, 2020	Apr. 23, 2020	Mar. 31, 2020	Mar. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Convertible Note Payable (Details) [Line Items]
Convertible notes			$ 430,000	$ 430,000							$ 551,100
Net proceed received			382,250	382,250
Net proceeds value			45,000	45,000
Origination fees			$ 2,750	$ 2,750
Notes bore interest, percentage			12.00%	12.00%
Securities purchase agreement description							On April 23, 2020, the Company closed on a Securities Purchase Agreement (the “April 2020 SPA”) with an accredited investor. Pursuant to the terms of the April 2020 SPA, the Company issued and sold to this investor a convertible promissory note in the aggregate principal amount of $57,750 and a warrant to purchase up to 144,375 shares of the Company’s common stock. The Company received net proceeds of $50,000, net of original issue discount of $5,000 and origination fees of $2,750. The Note bore interest at 12% per annum and was due and payable on January 23, 2021. The April 23, 2020 Note was repaid in full on August 24, 2020 and the 144,375 warrants were cancelled.		On March 30, 2020, the Company closed on a Securities Purchase Agreement (the “March 2020 SPA”) with an accredited investor. Pursuant to the terms of the March 2020 SPA, the Company issued and sold to this investor a convertible promissory note in the aggregate principal amount of $57,750 and a warrant to purchase up to 144,375 shares of the Company’s common stock. The Company received net proceeds of $50,000, net of original issue discount of $5,000 and origination fees of $2,750. The Note bore interest at 12% per annum and was due and payable on December 30, 2020. The March 30, 2020 Note was repaid in full on August 24, 2020 and the 144,375 warrants were cancelled.
Convertible Note Payable description										(i) the lowest Trading Price (as defined below) during the previous twenty-five Trading Day period ending on the latest complete Trading Day prior to the date of this Note, and (ii) the Variable Conversion Price (as defined below) (subject to equitable adjustments for stock splits, stock dividends or rights offerings by the Company). The “Variable Conversion Price” meant 60% multiplied by the Market Price (as defined herein) (representing a discount rate of 40%).
Aggregate shares of common stock (in Shares)										1,050,000
Exercise price (in Dollars per share)										$ 0.01
Common stock shares issued (in Shares)		1,008,000
Cashless exercise warrants (in Shares)		1,050,000
Derivative gain											69,793
Derivative expense											$ 90,623
Fair value of warrants						$ 14,498		$ 14,498
Shares of common stock (in Shares)											37,171,800
Conversion principal											$ 152,285
Warrants description											Additionally, the Company repaid principal of $393,215 and accrued interest of $15,917. Upon conversion, exercise or repayment, the respective derivative liabilities were marked to fair value at the conversion, repayment or exercise date and then the related fair value amount of $1,066,535 was reclassified to other income as part of gain or loss on extinguishment. Additionally, in 2020, upon repayment, the Company and Investor agreed to cancel 288,750 warrants and agreed to modify the exercise price of the remaining warrants to $0.01 per share (see Note 10 - warrants). Since the fair value of the warrants using the new exercise price was less than the initial fair value amount, no additional expense was recorded (see Note 10 – warrants).
Amortization of debt discount of debt discount										$ 171,875	$ 424,001
Limitation exceeds										9.99%
Beneficial conversion feature										$ 318,794
Convertible note payable										171,875
Accrued interest payable										25,863
Common Stock [Member]
Convertible Note Payable (Details) [Line Items]
Warrant to purchase shares of common stock (in Shares)			1,050,000	1,050,000
Beneficial conversion feature
Convertible Promissory Notes [Member]
Convertible Note Payable (Details) [Line Items]
Net proceeds value							$ 85,502
Conversion option derivatives							245,918
Derivative expense							$ 160,416
Accrued interest											36,244
Fees											2,500
Convertible Debt [Member]
Convertible Note Payable (Details) [Line Items]
Convertible notes											0
Amortization of debt discount of debt discount											$ 409,668
2021 [Member]
Convertible Note Payable (Details) [Line Items]
Securities purchase agreement description	On October 15, 2021, the Company entered into a Securities Purchase Agreement (the “SPA”) with Mercer Street Global Opportunity Fund, LLC (the “Investor”), pursuant to which the Company issued and sold to Investor a 10% Original Issue Discount Senior Convertible Promissory Note in the principal amount of $825,000 (the “Initial Note”) and five-year warrants to purchase up to 16,500,000 shares of the Company’s common stock at an exercise price of $0.05 per share, an amount equal to 50% of the conversion shares to be issued (the “Initial Warrants”). The Company received net proceeds of $680,000, which is net of original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000.				the Company issued 668,151 shares of its common stock to the placement agent as fee for the capital raise. The 668,151 shares of common stock issued were recorded as a debt discount of $14,064 based on the relative fair value method to be amortized over the life of the Note. The 16,500,000 Initial Warrants were valued at $347,142 using the relative fair value method and recorded as a debt discount to be amortized over the life of the note. The original issue discounts of $75,000, placement fees of $60,000, and legal fees of $10,000, aggregating $145,000, have been recorded as a debt discount to be amortized into interest expense over the twelve-month term of the note.
Additional purchase										$ 825,000
Original issue discount rate										10.00%
Exercise price per share (in Dollars per share)										$ 0.05
Conversion shares to be issued										50.00%
Interest rate bears										4.00%
Conversion price, per share (in Dollars per share)										$ 0.025
Average closing price per share (in Dollars per share)										$ 0.0175
Principal amount percentage										110.00%
Principal amount plus accrued interest										120.00%
Excess outstanding shares percentage										4.99%
Convertible note payables, description										Upon the occurrence of an event of default under the Notes, the Investor has the right to be prepaid at 125% of the outstanding principal balance and accrued interest, and interest accrues at 18% per annum. Events of default included, among other things,  (i)any default in the payment of (A) principal and interest payment under this Note or any other Indebtedness, or (B) Late Fees, liquidated damages and other amounts owing to the Holder of this Note, as and when the same shall become due and payable (whether on a Conversion Date, or the Maturity Date, or by acceleration or otherwise), which default, solely in the case of a default under clause (B) above, is not cured within five Trading Days;  (ii)the Company or any Subsidiary shall be subject to a Bankruptcy Event;  (iii)the SEC suspends the Common Stock from trading or the Company’s Common Stock is not listed or quoted for trading on a Trading Market which failure is not cured, if possible to cure, within the earlier to occur of 10 Trading Days after notice of such failure is sent by the Holder or by any other Holder to the Company or the transfer of shares of Common Stock through the Depository Trust Company System is no longer available or is subject to a “chill” by the Depository Trust Company or any successor;  (iv)the Company shall be a party to any Change of Control Transaction or shall agree to sell or dispose of all or in excess of 50% of its assets in one transaction or a series of related transactions (whether or not such sale would constitute a Change of Control Transaction);   (v)the Company incurs any Indebtedness other than Permitted Indebtedness;  (vi)the Company restates any financial statements included in its reports or registration statements filed pursuant to the Securities Act or the Exchange Act for any date or period from two years prior to the Original Issue Date of this Note and until this Note is or the Warrants issued to the Holder are no longer outstanding, if following first public announcement or disclosure that a restatement will occur the VWAP on the next Trading Day is 20% less than the VWAP on the prior Trading Day. For the purposes of this clause the next Trading Day if an announcement is made before 4:00 pm New York, NY time is either the day of the announcement or the following Trading Day; The Company has also granted the Investor a 12-month (or until the Notes are no longer outstanding) right to participate in specified future financings, up to a level of 30%.
Initial conversion price (in Dollars per share)										$ 0.025
Initial warrants										$ 347,142
Common shares issued value										14,064
Beneficial conversion feature										318,794
Aggregate non-cash debt discount										680,000
Convertible note payable										171,875
Accrued interest payable										$ 7,052

Convertible Note Payable (Det_2

Convertible Note Payable (Details) - Schedule of fair value of the derivative liabilities and warrants was estimated using the binomial valuation model	12 Months Ended
	Dec. 31, 2021
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Dividend rate
Minimum [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Term (in years)	3 months
Volatility	293.40%
Risk—free interest rate	0.12%
Maximum [Member]
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]
Term (in years)	5 years
Volatility	345.70%
Risk—free interest rate	0.39%

Convertible Note Payable (Det_3

Convertible Note Payable (Details) - Schedule of fair value of the stock warrants was estimated at issuance using the binomial valuation model	1 Months Ended
	Oct. 18, 2021
Schedule of fair value of the stock warrants was estimated at issuance using the binomial valuation model [Abstract]
Dividend rate
Term (in years)	5 years
Volatility	348.50%
Risk—free interest rate	1.16%

Convertible Note Payable (Det_4

Convertible Note Payable (Details) - Schedule of convertible notes payable - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of convertible notes payable [Abstract]
Convertible note payable	$ 825,000
Less: unamortized debt discount	(653,125)
Convertible note payable, net	171,875
Less: current portion of convertible note payable	(171,875)
Convertible note payable – long-term

Notes Payable (Details)

Notes Payable (Details) - USD ($)	Nov. 04, 2021	May 10, 2021	Nov. 14, 2018	Jul. 22, 2021	Apr. 28, 2020	Dec. 31, 2021	Dec. 31, 2020
Notes Payable (Details) [Line Items]
Maximum loan amount						$ 500,000	$ 156,200
Outstanding bear interest percentage			18.00%			18.00%
Loan agreement, description						In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018, the Company shall have 45 days (through and until February 15, 2019) to cure such violation and an establish accounts receivable plus inventory equal to the unpaid principal balance of the Note. Commencing March 31, 2019 and at all times thereafter through the remainder of the commitment period and for so long thereafter as there is any amount still due and owing under the Note, the Company must maintain an accounts receivable balances plus inventory such that the outstanding principal borrowed by Company under the Loan Agreement and Note is less than or equal to eighty five percent (85%) of accounts receivable plus fifty percent (50%) of inventory, all as measured at the same point in time.
Note balance due						$ 400,000
Principal amount						500,000	0
Accrued interest payable						25,863
Secured promissory note amount		$ 500,000
Annual accrued interest		8.00%
Interest rate percentage		18.00%
Capital Lease Amount				$ 95,013
Notes payable vehicles amount						78,925
Minimum [Member]
Notes Payable (Details) [Line Items]
Interest rate percentage				6.79%
Maximum [Member]
Notes Payable (Details) [Line Items]
Interest rate percentage				8.24%
PPP Note [Member]
Notes Payable (Details) [Line Items]
Principal amount	$ 61,200
Accrued interest payable	935					1,031	1,061
Interest rate percentage					1.00%
Loan payable					$ 156,200
Maturity date					Apr. 28, 2022
Payments of loan					$ 8,900
Administration amount	95,000
Interest amount	$ 1,442
Repayment of principal loan						12,271
Principal amount due						48,929	156,200
Interest expense						1,411	1,061
Notes Payable [Member]
Notes Payable (Details) [Line Items]
Principal amount						400,000	400,000
Accrued interest payable						$ 220,241	$ 148,241
Revolving Credit Facility [Member]
Notes Payable (Details) [Line Items]
Maximum loan amount			$ 400,000
Initial amount			$ 400,000
Outstanding bear interest percentage			12.00%

Notes Payable (Details) - Sched

Notes Payable (Details) - Schedule of notes payable - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of notes payable [Abstract]
Notes payable	$ 978,925	$ 400,000
Note payable – PPP note	48,929	156,200
Total notes payable	1,027,854	556,200
Less: current portion of notes payable	(488,414)	(521,138)
Notes payable – long-term	$ 539,440	$ 35,062

Notes Payable (Details) - Sch_2

Notes Payable (Details) - Schedule of future annual maturities of notes payable	Dec. 31, 2021USD ($)
Schedule of future annual maturities of notes payable [Abstract]
2022	$ 488,414
2023	530,720
2024	6,458
2025	2,262
Total notes payable on December 31, 2021	$ 1,027,854

Shareholders' Deficit (Details)

Shareholders' Deficit (Details) - USD ($)	May 01, 2022	Jan. 12, 2022	Dec. 08, 2021	Dec. 07, 2021	Oct. 15, 2021	Oct. 15, 2021	Oct. 01, 2021	Sep. 17, 2021	Jul. 22, 2021	Jul. 07, 2021	Jun. 03, 2021	May 01, 2021	Apr. 07, 2021	Mar. 08, 2021	Feb. 01, 2021	Jan. 18, 2021	Jan. 07, 2021	Jan. 06, 2021	Dec. 18, 2020	Oct. 09, 2020	Oct. 07, 2020	Oct. 06, 2020	Oct. 01, 2020	Jul. 02, 2020	Jul. 01, 2020	May 08, 2020	Apr. 17, 2020	Apr. 01, 2020	Jan. 13, 2020	Dec. 12, 2019	Dec. 12, 2019	Oct. 18, 2021	Aug. 25, 2021	Aug. 23, 2021	May 04, 2021	Apr. 28, 2021	Mar. 19, 2021	Feb. 24, 2021	Dec. 21, 2020	Aug. 24, 2020	Aug. 20, 2020	Mar. 31, 2020	Feb. 20, 2020	Feb. 18, 2020	Apr. 28, 2021	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2021	Dec. 31, 2020	Jan. 06, 2022	Apr. 28, 2020	Oct. 16, 2019
Shareholders' Deficit (Details) [Line Items]
Preferred stock price per share (in Dollars per share)																																																$ 0.1	$ 0.1
Amortized discount																																																$ 171,875	$ 424,001
Accrued dividend payable																																																16,641	2,476
Cash proceeds from investor																																																	100,000
Interest expense																																																$ 282,959	$ 751,184
Agreement description																																																	the Company entered into subscription agreements with an accredited investor whereby the investor agreed to purchase an aggregate of purchase 7,000 shares of the Company’s Series C Convertible Preferred Stock for $700,000, or $100.00 per share (the “Stated Value”), which were used from working capital purposes.
Share issued (in Shares)							6,000,000																									668,151
Common shares converted (in Shares)																											203,125
Common shares per share (in Dollars per share)							$ 0.0346		$ 0.0248											$ 0.012	$ 0.0085	$ 0.008	$ 0.011					$ 0.04	$ 0.04													$ 0.04							$ 0.054
Gross proceeds																								$ 280,000		$ 161,000
Investor purchase (in Shares)																								21,538,462		7,000,000
Common shares per share (in Dollars per share)								$ 0.031																$ 0.013		$ 0.023																						$ 0.001	$ 0.001		$ 0.04
Purchased shares (in Shares)																																																	1,851,852
Restricted common shares (in Shares)								1,000,000												500,000	9,000,000	1,275,000	25,000					200,000														500,000
Value of restricted stock common shares							$ 207,600	$ 30,600												$ 6,000	$ 76,500	$ 10,200	$ 275					$ 8,000														$ 20,000
Stock-based professional fees																																																$ 43,250	$ 10,200
Consulting fees																																																5,000	15,000
Stock-based professional fees																																																103,800	38,250
Research and development expense																																																	275
Stock-based professional fees										$ 72,500	$ 6,000																																					1,031,540	546,979
Prepaid expenses																																																$ 103,800
Vesting period																																																6 months
Common stock, description													On April 7, 2021, the Company issued 2,500,000 shares of its common stock for investor relations services to be rendered. These shares were valued at $135,000, or $0.054 per common share, based on the quoted closing price of the Company’s common stock on the measurement date. In connection with these shares, the Company recorded stock-based professional fees of $135,000.
Company issued (in Shares)										2,500,000	200,000																							500,000
Common share value										$ 72,500	$ 6,000																							$ 19,000
Closing price per share (in Dollars per share)										$ 0.029	$ 0.03																							$ 0.038
Prepaid expenses																																																$ 38,250
Accretion of stock-based professional fees																																																5,000
Aggregate common shares (in Shares)																																																			6,750,000
Stock based compensation value																																																			$ 270,000
Vested date														May 1, 2022																															May 1, 2021
Equity vested rate																																																			100.00%
Issued shares of common stock (in Shares)		120															1,008,000
Compensation expense related to stock options																																																0	609,662
Stock-based compensation expense on granted non-vested																																																267,530	446,064
Unrecognized compensation expense																																																49,320
Description of issuance of common stock									the Company closed the Exchange Agreement and acquired 80% of the Mobile Member Units (see Note 3). The Mobile Member Units were exchanged for restricted shares of the Company’s common stock, in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing as defined in the Exchange Agreement. In connection with the Exchange Agreement, the Company issued 28,021,016 shares of its common stock. These shares were valued at $694,921, or $0.0248 based on the quoted closing price of the Company’s common stock on the measurement date.
Shares of common stock upon conversion (in Shares)																													151,456
Accounts payable																													$ 6,058
convertible debt description																																The 668,151 shares of common stock issued were recorded as a debt discount of $14,064 based on the relative fair value method to be amortized over the life of the Note (See Note 8).
Accrued interest																											$ 16,250
Common stock conversion shares (in Shares)																			547,945
Accrued deferred compensation liability																			$ 8,000
Fair value of the award amount																			$ 12,603
Fair market value of per share (in Dollars per share)																			$ 0.023
Deferred compensation description																			Since the deferred compensation amount converted of $8,000 was lower than fair value of shares issued, the Company recorded additional stock-based compensation of $4,603.
Cashless exercise of warrants (in Shares)																	1,050,000
Total unrecognized compensation expense related to unvested stock options																																																$ 0	0
Warrant description																																																On March 30, 2020 and on April 23, 2020, in connection with Purchase Agreements with an accredited investor (See Note 8), the Company issued warrants to purchase an aggregate amount up to 288,750 shares of the Company’s common stock (the “Warrants”). The Warrants were exercisable at any time on or after the date of the issuance and entitled this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable. Under the terms of the Warrants, the holder was entitled to exercise the Warrants to purchase up to 288,750 shares of the Company’s common stock at an initial exercise price of $0.10, subject to adjustment as detailed in the Warrants. In connection with the issuance of the warrants, on the initial measurement date, the relative fair value of the warrants of $14,498 was recorded as a debt discount and an increase in paid-in capital (See Note 8). In September 2020, in connection with the repayment of the debt, these warrants were cancelled. During the year ended December 31, 2020, the Company issued common shares related to the sale of common stock and issued shares upon the conversion of convertible debt at prices lower than the warrant exercise price of $0.10 and accordingly, the warrant down-round provisions were triggered. As a result, the warrant exercise price was reduced to $0.003 per share. As a result of the trigger of down-round provisions, the Company calculated the difference between the warrants fair value on the date the down round feature was triggered using the current exercise price and the new exercise price. If applicable, additional expense shall be recorded as an increase in accumulated deficit and increase in paid-in capital and increased the net loss to common shareholders by the same amount. Since the fair value of the warrants using the new exercise price was less than the initial fair value amount, no additional expense was recorded. In connection with the repayment of the debt, the Company and investor agreed upon a fixed warrant exercise price of $0.01 per share. On January 7, 2021, the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant. On October 15, 2021, in connection with a Securities Purchase Agreements with an accredited investor (See Note 8), the Company issued warrants to purchase an aggregate amount up to 16,500,000 shares of the Company’s common stock (the “Warrants”). The Warrants were exercisable at any time on or after the date of the issuance and entitled this investor to purchase shares of the Company’s common stock for a period of five years from the initial date the warrants become exercisable.
Warrant purchase, description																	the Company issued 1,008,000 shares of its common stock in connection with the cashless exercise of 1,050,000 warrants. The exercise price was based on contractual terms of the related warrant.
Aggregate amount			$ 309,615			$ 16,500,000
Warrant exercise Price (in Dollars per share)						$ 0.05
Fair value warrants amount					$ 347,142
2018 Long-Term Incentive Plan [Member]
Shareholders' Deficit (Details) [Line Items]
Stock option, description																																																The aggregate number of shares of common stock and number of shares of the Company’s common stock that may be subject to incentive stock options granted under the 2018 Plan is 50,000,000 shares, of which 11,445,698 shares have been issued or granted under incentive stock options and 29,451,070 shares of restricted stock have been issued as of December 31, 2021.
Aggregate shares of common stock (in Shares)																																																25,000,000
Description of options to acquire common stock																																																The exercise price of options granted under our 2018 Plan must at least be equal to the fair market value of the Company’s common stock on the date of grant and the term of an option may not exceed ten years, except that with respect to an incentive stock option granted to any employee who owns more than 10% of the voting power of all classes of the Company’s outstanding stock as of the grant date the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date.
Minimum [Member]
Shareholders' Deficit (Details) [Line Items]
Preferred stock stated value (in Dollars per share)																																																		$ 0.024
MobileTintLLC[Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)									$ 0.025
Issued shares of common stock (in Shares)									976,500
Value of issued shares of common stock									$ 24,413
Compensation expense related to stock options									$ 24,413
Warrant [Member]
Shareholders' Deficit (Details) [Line Items]
Purchase of shares (in Shares)						16,500,000
Business Development [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)														$ 0.066	$ 0.078			$ 0.1
Restricted common shares (in Shares)																		100,000
Value of restricted stock common shares														$ 49,500	$ 54,600			$ 10,000
Stock-based professional fees																																																$ 10,000
Aggregate shares of common stock (in Shares)														750,000	700,000
Vesting period																																																2 months 12 days
Business Development [Member]
Shareholders' Deficit (Details) [Line Items]
Stock-based professional fees																																																$ 49,500
Series A Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Shares designated (in Shares)																																																				800,000
Preferred stock price per share (in Dollars per share)																																																				$ 0.1
Preferred stock stated value (in Dollars per share)																																																				$ 1
Preferred Stock dividend Rate																																																4.00%
Preferred stock dividend increased																																																22.00%
Issuance date																																																180 years
Mandatory redemption date description																																																On the earlier to occur of (i) the date which is eighteen months following the Issuance Date and (ii) the occurrence of an Event of Default (the “Mandatory Redemption Date”), the Company shall redeem all of the shares of Series A Preferred Stock of the Holders (which have not been previously redeemed or converted). Within five days of the Mandatory Redemption Date, the Company shall make payment to each Holder of an amount in cash equal to (i) the total number of Series A Preferred Stock held by such Holder multiplied by (ii) the Stated Value plus the Adjustment Amount.
Variable conversion price percentage																																																81.00%
Discount rate percentage																																																19.00%
Aggregate debt premium																																																	$ 42,553
Preferred stock, par value description																																																	Series A Preferred stock, par value $0.10 for $129,000, or $0.833 per share.
Aggregate shares purchase (in Shares)																																																	154,800
Cash proceeds																																																$ 120,000
Net fees																																																9,000
Amortized discount																																																$ 9,000
Amortization of discount charged to interest expense																																																	$ 14,333
Accrued dividend payable																																								$ 1,562									4,852
Redeemed remaining share (in Shares)																																								103,200
Cash proceeds from investor																																								$ 117,047
Stated redemption value																																								103,200
Redemption penalties																																								12,285
Remaining premium balance																																								24,207
Gain on extinguishment																																								$ 24,207
Preferred stock balance																																																	0
Interest expense																																																	$ 126,423
convertible debt description																																																	The conversion price was based on contractual terms of the related Series A preferred shares. Upon conversion, the Company reclassified put premium of $49,543 to paid-in capital.
Description of options to acquire common stock																																																	The conversion price was based on contractual terms of the related Series A preferred shares. Upon conversion, the Company reclassified put premium of $49,543 to paid-in capital.
Series B Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Shares designated (in Shares)																																																100,000	100,000
Preferred Stock dividend Rate																																																2.00%
Accrued dividend payable																																																$ 14,165	$ 2,476
Preferred stock balance																																																738,611	429,446
Designations established share (in Shares)																															100,000
Preferred Stock par value (in Shares)																														0.1	0.1
Stated value																																																$ 1,000
Stock option, description																																																The Series B is convertible into common stock at the option of a holder or if the closing price of the common stock exceeds 400% of the Conversion Price for a period of twenty consecutive trading days, at the option of the Company. Conversion Price means a price per share of the common stock equal to 100% of the lowest daily volume weighted average price of the common stock during the two years preceding or subsequent two years following the Issuance Date, subject to adjustment as otherwise provided in the Certificate of Designations (the “Conversion Price”).
Accrued compensation																$ 295,000														$ 108,000	$ 108,000								$ 318,970											$ 278,653
Agreed settlement shares (in Shares)																														108									319
Stock-based compensation																																							$ 1,048,143
Accrued compensation shares (in Shares)																295
Stock based compensation																$ 3,778,810
Vested shares (in Shares)												158
Stated value																																																$ 721,970	$ 426,970
Series C Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Shares designated (in Shares)																																																100,000	100,000
Preferred stock stated value (in Dollars per share)																																														$ 100	$ 100
Preferred Stock dividend Rate																																									2.00%
Aggregate shares purchase (in Shares)																																														6,300
Accrued dividend payable																																	$ 1,509,523					$ 2,845,238										$ 39,012	$ 6,031
Preferred stock balance																																																1,907,012	1,336,031
Designations established share (in Shares)																																									100,000
Preferred Stock par value (in Shares)																																									0.1					630,000	630,000
Stated value																																									$ 100								1,330,000
Stated value				$ 12,000
Percentage of stated value																																									150.00%
Outstanding shares percent																																				4.99%
Non-cash deemed dividend																																																	1,525,873
Purchase of shares (in Shares)																																	3,000					2,500
Share issued (in Shares)				1,500,000
Common shares converted (in Shares)				120
Stated value																																																1,868,000
Series C Preferred Stock [Member] | Maximum [Member]
Shareholders' Deficit (Details) [Line Items]
Stated value																																	$ 300,000					$ 250,000
Series C Preferred Stock [Member] | Minimum [Member]
Shareholders' Deficit (Details) [Line Items]
Stated value																																	$ 100					$ 100
Series C Preferred Stock [Member] | Preferred Stock Dividends [Member]
Shareholders' Deficit (Details) [Line Items]
Accrued dividend payable																																																32,981	$ 6,031
Forecast [Member] | Series B Preferred Stock [Member]
Shareholders' Deficit (Details) [Line Items]
Vested shares (in Shares)	564
Sales Manager [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)															$ 0.078
Issued shares of common stock (in Shares)															200,000
Value of issued shares of common stock															$ 15,600
Officer [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)														$ 0.066
Restricted common shares (in Shares)														2,500,000
Value of restricted stock common shares														$ 165,000
Investor [Member]
Shareholders' Deficit (Details) [Line Items]
Cash proceeds from investor																																												$ 280,000
Purchase of shares (in Shares)																																												7,000,000
Common shares per share (in Dollars per share)																																												$ 0.04
Shares Issued for Accounts Payable [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)																																			$ 0.031
Company issued (in Shares)																																			3,801,224
Accounts payable																																			$ 117,838
Issued for Debt Conversion [Member]
Shareholders' Deficit (Details) [Line Items]
Debt conversion, description																																																	the Company issued 37,171,800 shares of its common stock upon the conversion of convertible notes with bifurcated embedded conversion option derivatives including principal of $152,285, accrued interest of $36,244, and fees of $2,500. The conversion price was based on contractual terms of the related debt. The Company accounted for the partial conversion of these convertible notes pursuant to the guidance of ASC 470-20, Debt with Conversion and Other Options. Under ASC 470-20, during the year ended December 31, 2020, the Company recognized an aggregate loss on debt extinguishment upon conversion in the amount of $297,919 which is associated with the different between the fair market value of the shares issued upon conversion of $450,204 and the conversion price and is equal to the fair value of the additional shares of common stock transferred upon conversion.
Consulting Agreement [Member]
Shareholders' Deficit (Details) [Line Items]
Common shares per share (in Dollars per share)																									$ 0.013																		$ 0.04
Restricted common shares (in Shares)																									500,000																		1,250,000
Value of restricted stock common shares																									$ 6,500																		$ 50,000
Stock-based professional fees																																															$ 50,000
Stock-based professional fees																																																6,729	$ 6,000
Prepaid expenses																																																$ 12,271
Vesting period																																																8 months 1 day
Investor Relations Services [Member]
Shareholders' Deficit (Details) [Line Items]
Stock-based professional fees																																																$ 38,250	$ 6,500
Vesting period																																																3 months
Advisory and Consulting Services [Member]
Shareholders' Deficit (Details) [Line Items]
Stock-based professional fees																																																$ 51,350
Prepaid expenses																																																$ 3,250
General Release Agreement [Member]
Shareholders' Deficit (Details) [Line Items]
Accrued compensation																																					$ 40,625
Stock-based compensation																																					$ 15,116
Common shares per share (in Dollars per share)																																					$ 0.059
Issued shares of common stock (in Shares)																																					944,767
Value of issued shares of common stock																																					$ 55,741

Shareholders' Deficit (Detail_2

Shareholders' Deficit (Details) - Schedule of redemption period	12 Months Ended
	Dec. 31, 2021
Debt Instrument, Redemption, Period One [Member]
Shareholders' Deficit (Details) - Schedule of redemption period [Line Items]
Redemption period, description	1. The period beginning on the date of the issuance of shares of Series A Preferred Stock and ending on the date which is sixty days following the Issuance Date.
Redemption percentage	100.00%
Debt Instrument, Redemption, Period Two [Member]
Shareholders' Deficit (Details) - Schedule of redemption period [Line Items]
Redemption period, description	2. The period beginning on the date that is sixty-one days from the Issuance Date and ending ninety days following the Issuance Date.
Redemption percentage	107.00%
Debt Instrument, Redemption, Period Three [Member]
Shareholders' Deficit (Details) - Schedule of redemption period [Line Items]
Redemption period, description	3. The period beginning on the date that is ninety-one days from the Issuance Date and ending one hundred twenty days following the Issuance Date.
Redemption percentage	112.00%
Debt Instrument, Redemption, Period Four [Member]
Shareholders' Deficit (Details) - Schedule of redemption period [Line Items]
Redemption period, description	4. The period beginning on the date that is one hundred twenty-one days from the Issuance Date and ending one hundred fifty days following the Issuance Date.
Redemption percentage	117.00%
Debt Instrument, Redemption, Period Five [Member]
Shareholders' Deficit (Details) - Schedule of redemption period [Line Items]
Redemption period, description	5. The period beginning on the date that is one hundred fifty-one days from the Issuance Date and ending one hundred eighty days following the Issuance Date.
Redemption percentage	120.00%

Shareholders' Deficit (Detail_3

Shareholders' Deficit (Details) - Schedule of activity related to non-vested shares - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of activity related to non-vested shares [Abstract]
Number of Non-Vested Shares, Beginning balance	23,826,926	17,675,299
Weighted Average Grant Date Fair Value, Beginning balance	$ 0.16	$ 0.23
Number of Non-Vested Shares, Granted	6,194,767	7,450,000
Weighted Average Grant Date Fair Value, Granted	$ 0.06	$ 0.04
Number of Non-vested Shares, Forfeited	(700,000)
Weighted Average Grant Date Fair Value, Forfeited	$ (0.07)
Number of Non-Vested Shares, Shares vested	(15,051,573)	(1,298,373)
Weighted Average Grant Date Fair Value, Shares vested	$ (0.14)	$ (0.41)
Number of Non-Vested Shares, Ending balance	14,270,120	23,826,926
Weighted Average Grant Date Fair Value, Ending balance	$ 0.14	$ 0.16

Shareholders' Deficit (Detail_4

Shareholders' Deficit (Details) - Schedule of stock option activities - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]
Number of Options, Balance Outstanding, Beginning		8,445,698	2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning		$ 0.4	$ 0.1
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning
Aggregate Intrinsic Value, Balance Outstanding, Beginning
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Balance Outstanding, Ending		8,445,698	2,050,000
Stock options [Member]
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]
Number of Options, Balance Outstanding, Beginning	8,445,698	8,445,698
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Balance Outstanding, Ending	8,445,698	8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending	$ 0.4	$ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending	4 years 1 month 6 days	5 years 1 month 6 days
Aggregate Intrinsic Value, Balance Outstanding, Ending	$ 0	$ 48,000
Number of Options, Exercisable	8,445,698
Weighted Average Exercise Price, Exercisable	$ 0.4
Weighted Average Remaining Contractual Term (Years), Exercisable,	4 years 1 month 6 days
Aggregate Intrinsic Value, Exercisable	$ 0

Shareholders' Deficit (Detail_5

Shareholders' Deficit (Details) - Schedule of warrant activities - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]
Number of Warrants, Balance Outstanding, Beginning	8,445,698	2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning	$ 0.4	$ 0.1
Number of Warrants, Exercised
Number of Warrants, Balance Outstanding, Ending		8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending		$ 0.4
Aggregate Intrinsic Value, Balance Outstanding, Ending
Warrant [Member]
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]
Number of Warrants, Balance Outstanding, Beginning	2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning	$ 0.05
Number of Warrants, Exercised	(1,050,000)	288,750
Weighted Average Exercise Price, Exercised	$ (0.01)	$ 0.1
Aggregate Intrinsic Value, Exercised
Number of Warrants, Cancelled		(288,750)
Weighted Average Exercise Price, Cancelled		$ (0.1)
Number of Warrants, Balance Outstanding, Ending	17,500,000	2,050,000
Weighted Average Exercise Price, Balance Outstanding, Ending	$ 0.05	$ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending	4 years 8 months 1 day	3 years 7 months 28 days
Aggregate Intrinsic Value, Balance Outstanding, Ending		$ 137,000
Number of Warrants, Exercisable	17,500,000
Weighted Average Exercise Price, Exercisable	$ 0.05
Weighted Average Remaining Contractual Term (Years), Exercisable	4 years 8 months 1 day
Aggregate Intrinsic Value, Exercisable
Number of Warrants, Granted	16,500,000
Weighted Average Exercise Price, Granted	$ 0.05
Aggregate Intrinsic Value, Granted

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($)

Jan. 06, 2022

Dec. 08, 2021

Oct. 15, 2021

Jul. 21, 2021

Jan. 18, 2021

Apr. 25, 2018

Oct. 18, 2017

Dec. 31, 2016

Dec. 31, 2015

Dec. 31, 2013

Dec. 31, 2021

Oct. 01, 2021

Jul. 31, 2021

Jul. 22, 2021

Dec. 31, 2020

Oct. 09, 2020

Oct. 07, 2020

Oct. 06, 2020

Oct. 01, 2020

Jun. 30, 2020

Apr. 01, 2020

Mar. 31, 2020

Jan. 13, 2020

Commitments and Contingencies (Details) [Line Items]

Company filed claims

$ 16,000

Accrued compensation

$ 18,250

Common shares per share (in Dollars per share)

$ 0.0346

$ 0.0248

$ 0.054

$ 0.012

$ 0.0085

$ 0.008

$ 0.011

$ 0.04

$ 0.04

$ 0.04

Bonus to officers and an employee

$ 330,000

Annual base salary

$ 240,000

Base salary percentage

50.00%

Base salary allocated expenses, percentage

50.00%

Base salary bonus, percentage

50.00%

Aggregate amount

$ 309,615

$ 16,500,000

Annual compensation, percentage

50.00%

Other commitments, description

This bonus will be paid 10% in cash ($30,962) which was paid in December 2021 and 90% in equity amounting $278,653 which as of December 31, 2021 has been accrued and included in accrued compensation on the accompanying consolidated balance sheet.

Exercise price per share (in Dollars per share)

$ 0.85

Subsequent Event [Member]

Commitments and Contingencies (Details) [Line Items]

Bonus owed to its executive officers

$ 278,653

Subsequent Event [Member] | Series B convertible preferred stock [Member]

Commitments and Contingencies (Details) [Line Items]

Convertible preferred stock (in Shares)

278

Employment Agreements [Member] | Mr. Scott Silverman [Member]

Commitments and Contingencies (Details) [Line Items]

Description of employment agreement

As consideration for these services, the employment agreement provides Mr. Silverman with the following compensation and benefits:  ●An annual base salary of $300,000, with a 10% increase on each anniversary date contingent upon achieving certain performance objectives as set by the Board. Until the Company raises $1,000,000 in debt or equity financing after entering into this agreement, Mr. Silverman will receive ½ of the base salary on a monthly basis with the other ½ being deferred. Upon the financing being raised, Mr. Silverman will receive the deferred portion of his compensation and his base salary will be paid in full moving forward.    ●After the first $500,000 of equity investments is raised by the Company, after entering into this employment agreement, Mr. Silverman will receive a capital raise success bonus of 5% of all equity capital raised from investors/lenders introduced by him to the Company.    ●Annual cash performance bonus opportunity as determined by the Board.    ●An option to acquire 3,000,000 common shares of the Company, with a strike price of $0.31 per unit. These options vested pro rata on a monthly basis for the term of the employment agreement. On each anniversary, Mr. Silverman will be eligible to be granted a minimum of 500,000 stock options of the Company at a strike price of $0.85 per common unit contingent upon the achievement of certain performance objectives.    ●Certain other employee benefits and perquisites, including reimbursement of necessary and reasonable travel and participation in retirement and welfare benefits.

Financing received

$ 1,240,000

Percentage of bonus provision

5.00%

Term of base salary

1 year

Common shares per share (in Dollars per share)

$ 0.85

Allowance amount

$ 10,000

Licensing Agreements [Member]

Commitments and Contingencies (Details) [Line Items]

Non-refundable license fee

$ 10,000

Percentage of royalty payments on net sales

5.00%

Subscription Agreements [Member]

Commitments and Contingencies (Details) [Line Items]

Common shares per share (in Dollars per share)

$ 0.85

$ 0.77

Anti-dilution rights on common stock sales (in Shares)

1,175,902

3,880,480

2,425,300

Subsequent investments based upon enterprise value

$ 2,000,000

Subscription Agreements [Member] | Minimum [Member]

Commitments and Contingencies (Details) [Line Items]

Common shares per share (in Dollars per share)

$ 0.85

Subscription Agreements [Member] | C-Bond Systems, LLC [Member]

Commitments and Contingencies (Details) [Line Items]

Common shares per share (in Dollars per share)

$ 0.77

Income Taxes (Details)

Income Taxes (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Income Tax Disclosure [Abstract]
Net operating loss carryforward	$ 9,229,000
Increase in valuation allowance	$ 602,235

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of income taxes at the effective statutory rate - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Schedule of income taxes at the effective statutory rate [Abstract]
Income tax benefit at U.S. statutory rate	$ (1,497,060)	$ (931,233)
Non-deductible expenses	894,825	457,894
Change in valuation allowance	602,235	473,339
Total provision for income tax

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of company’s approximate net deferred tax asset - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of company’s approximate net deferred tax asset [Abstract]
Net operating loss carryforward	$ 1,938,102	$ 1,335,867
Total deferred tax asset before valuation allowance	1,938,102	1,335,867
Valuation allowance	(1,938,102)	(1,335,867)
Net deferred tax asset

Concentrations (Details)

Concentrations (Details)	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020
Concentrations (Details) [Line Items]
Cash (in Dollars)	$ 132,000
FDIC coverage (in Dollars)	$ 250,000
Concentration risk percentage		40.10%
Number of customers	3	1
Minimum [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage		18.60%
Maximum [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage		21.50%
Customer One [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage	17.40%
Customer Two [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage	15.30%
Customer Three [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage	11.50%
Total sales [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage	44.20%	10.00%
Number of customers		2
Accounts Receivable [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage	21.40%	64.00%
Number of customers	1	1
United States [Member] | Total sales [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage		40.10%
India [Member] | Total sales [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage		21.50%
Number of customers		1
Philippines [Member] | Total sales [Member]
Concentrations (Details) [Line Items]
Concentration risk percentage		18.60%

Segment Reporting (Details)

Segment Reporting (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting [Abstract]
Number of reportable business segment	2	1

Segment Reporting (Details) - S

Segment Reporting (Details) - Schedule of reportable business segments - USD ($)		12 Months Ended
		Dec. 31, 2021	Dec. 31, 2020
Revenues:
Revenues		$ 1,476,828	$ 555,863
Depreciation and amortization:
Depreciation and amortization		45,967	14,093
Interest expense:
Interest expense		282,959	751,184
Net (loss) income:
Net (loss) income		(7,128,858)	(4,434,443)
C-Bond [Member]
Revenues:
Revenues		434,811	555,863
Depreciation and amortization:
Depreciation and amortization		9,889	14,093
Interest expense:
Interest expense		1,372	402
Net (loss) income:
Net (loss) income		(2,001,725)	(2,393,269)
Mobile Tint [Member]
Revenues:
Revenues		1,042,017
Depreciation and amortization:
Depreciation and amortization		36,078
Interest expense:
Interest expense		3,354
Net (loss) income:
Net (loss) income		77,626
Other Segments [Member]
Interest expense:
Interest expense	[1]	278,233	750,782
Net (loss) income:
Net (loss) income	[1]	$ (5,204,759)	$ (2,041,174)
[1]	The Company does not allocate any general and administrative expense of its holding company activities to its reportable segments, because these activities are managed at the corporate level.

Segment Reporting (Details) -_2

Segment Reporting (Details) - Schedule of identifiable long-lived tangible assets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting (Details) - Schedule of identifiable long-lived tangible assets [Line Items]
Identifiable long-lived tangible assets	$ 135,022	$ 18,683
C-Bond [Member]
Segment Reporting (Details) - Schedule of identifiable long-lived tangible assets [Line Items]
Identifiable long-lived tangible assets	8,794	18,683
Mobile Tint [Member]
Segment Reporting (Details) - Schedule of identifiable long-lived tangible assets [Line Items]
Identifiable long-lived tangible assets	$ 126,228

Revenue Recognition (Details) -

Revenue Recognition (Details) - Schedule of revenue by product - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenue from External Customer [Line Items]
Total	$ 1,476,828	$ 555,863
C-Bond Secure multi-purpose and BRS ballistic resistant glass protection systems [Member]
Revenue from External Customer [Line Items]
Total	184,424	155,755
C-Bond Nanoshield solution sales [Member]
Revenue from External Customer [Line Items]
Total	222,999	118,081
Disinfection products [Member]
Revenue from External Customer [Line Items]
Total	7,306	250,208
C-Bond installation and other services [Member]
Revenue from External Customer [Line Items]
Total	12,143	8,992
Window tint installation and sales recognized over time [Member]
Revenue from External Customer [Line Items]
Total	1,042,017
Freight and delivery [Member]
Revenue from External Customer [Line Items]
Total	$ 7,939	$ 22,827

Operating Lease Right-of-Use _3

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities (Details) - USD ($)	May 12, 2021	Sep. 30, 2021	Oct. 31, 2019	Dec. 31, 2021	Dec. 31, 2020	Oct. 31, 2020
Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities [Abstract]
Lease agreement, description			the Company entered into an 18-month lease agreement for the lease of office and warehouse space under a non-cancelable operating lease through May 31, 2021. From the lease commencement date of December 1, 2019 until November 30, 2020, monthly rent shall be $4,444 and from December 1, 2020 to May 31, 2021, monthly rent shall be $4,577 per month.
Lease cost	$ 5,283
Rent payable per month		$ 365		$ 5,600
Exchange agreement, description				The Company’s obligation as Guarantor of the Lease will terminate upon the occurrence of earlier of the following: (i) the date of Guarantor’s acquisition of 100% of the ownership interests of Mobile; (ii) the date that Guarantor beneficially owns less than an eighty percent (80%) ownership interest in Mobile; or (iii) two (2) years from and after the effective date of the guaranty.
Rental expenses				$ 119,192	$ 95,811
Operating lease liability discount rate						12.00%

Operating Lease Right-of-Use _4

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities (Details) - Schedule of right-of-use asset - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of right-of-use asset [Abstract]
Office leases and office equipment right of use assets	$ 269,590	$ 74,296
Less: accumulated amortization	(18,418)	(52,524)
Balance of ROU assets	$ 251,172	$ 21,772

Operating Lease Right-of-Use _5

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities (Details) - Schedule of operating lease liabilities related to the ROU assets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Schedule of operating lease liabilities related to the ROU assets [Abstract]
Lease liabilities related to office leases right of use assets	$ 251,246	$ 22,216
Less: current portion of lease liabilities	(44,927)	(22,216)
Lease liabilities – long-term	$ 206,319

Operating Lease Right-of-Use _6

Operating Lease Right-of-Use (“Rou”) Assets and Operating Lease Liabilities (Details) - Schedule of future minimum base lease payments due under non-cancelable operating leases	Dec. 31, 2021USD ($)
Schedule of future minimum base lease payments due under non-cancelable operating leases [Abstract]
2022	$ 71,578
2023	71,578
2024	71,578
2025	70,483
2026	39,200
Total minimum non-cancelable operating lease payments	324,417
Less: discount to fair value	(73,171)
Total lease liability on December 31, 2021	$ 251,246

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Related Party Transactions (Details) [Line Items]
Recognized sales	$ 3,750
Sales and Accounts Receivable [Member]
Related Party Transactions (Details) [Line Items]
Recognized sales	1,200
Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Due from related parties amount	$ 0	$ 5,526

Restatement (Details)

Restatement (Details)	12 Months Ended
	Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]
Management analysis description	Based on management’s analysis, the Company determined that a sale in the amount of $102,569 that was recorded in December 2020 did not meet the Company’s revenue recognition policy pursuant to ASC 606 and should not have been reflected as a sale. Additionally, in the same period, in connection with the Company’s analysis of collectability, the Company recorded a bad debt allowance and a related bad debt expense of $102,569. Since the sale and related allowance for bad debt should not have been recorded, the Company is restating its consolidated financial statements to reduce sales and bad debt expense by $102,569.

Restatement (Details) - Schedu

Restatement (Details) - Schedule of consolidated statement of operations	12 Months Ended
	Dec. 31, 2021USD ($)
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Sales	$ 658,432
Operating Expenses:
General and administrative expenses – bad debt expense	588,302
Total Operating Expenses	4,892,959
Loss from Operations	(4,477,033)
Net loss	(4,434,443)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	202,480
Change in operating assets and liabilities:
Accounts receivable	(130,188)
NET CASH USED IN OPERATING ACTIVITIES	(1,783,027)
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Sales	(102,569)
Operating Expenses:
General and administrative expenses – bad debt expense	(102,569)
Total Operating Expenses	(102,569)
Loss from Operations
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	(102,569)
Change in operating assets and liabilities:
Accounts receivable	102,569
NET CASH USED IN OPERATING ACTIVITIES
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Sales	555,863
Operating Expenses:
General and administrative expenses – bad debt expense	485,733
Total Operating Expenses	4,790,390
Loss from Operations	(4,477,033)
Net loss	(4,434,443)
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense	99,911
Change in operating assets and liabilities:
Accounts receivable	(27,619)
NET CASH USED IN OPERATING ACTIVITIES	$ (1,783,027)

Subsequent Events (Details)

Subsequent Events (Details)	Mar. 24, 2022	Mar. 14, 2022	Jan. 12, 2022USD ($)shares	Jan. 06, 2022USD ($)$ / sharesshares	Jan. 07, 2021shares	Dec. 31, 2021	Jan. 18, 2021USD ($)	Dec. 21, 2020USD ($)	Dec. 12, 2019USD ($)
Subsequent Events (Details) [Line Items]
Shares issued | shares			1,543,151	90,859
Conversion of Stock, Shares Issued | shares			120		1,008,000
Redemption value (in Dollars) | $			$ 12,000
Conversion of accounts payable (in Dollars) | $				$ 2,180
Investor purchase ,description	which were valued at $14,250, or $0.0285 per common share, based on the quoted closing price of the Company’s common stock on the measurement date.
Securities purchase, description		the Company entered into an Original Issue Discount Promissory Note and Security Agreement (the “March 2022 Note”) in the principal amount of $197,500 with Mercer Street Global Opportunity Fund, LLC (the “Investor”). The March 2022 Note was funded on March 14, 2022 and the Company received net proceeds of $175,000 which is net of an Original Issue Discount of $22,500, which included $5,000 of the Investor’s legal fees.
Accrued interest						3.00%
Shares , description						the Company issued 823,529 shares of its common stock to the placement agent as fee for the capital raise. The 823,529 shares of common stock issued were recorded as a debt discount of $12,963 based on the relative fair value method to be amortized over the life of the Note.
Minimum [Member]
Subsequent Events (Details) [Line Items]
Conversion price per share (in Dollars per share) | $ / shares				$ 0.024
Trading period	500,000
Series B Preferred Stock [Member]
Subsequent Events (Details) [Line Items]
Accrued compensation (in Dollars) | $				$ 278,653			$ 295,000	$ 318,970	$ 108,000
Shares issued | shares				278